<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pcbi</journal-id><journal-id journal-id-type="flc">plcb</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pcbi.0020038</article-id><article-id pub-id-type="sici">plcb-02-04-07</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Evolutionary Biology</subject><subject>Genetics and Genomics/Comparative Genomics</subject><subject>Computational Biology</subject></subj-group></article-categories><title-group><article-title>Positive Selection, Relaxation, and Acceleration in the Evolution of
					the Human and Chimp Genome</article-title><alt-title alt-title-type="running-head">Adaptive Evolution in Hominids</alt-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Arbiza</surname><given-names>Leonardo</given-names></name><xref ref-type="aff" rid="aff1">
						<sup>1</sup>
					</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dopazo</surname><given-names>Joaquín</given-names></name><xref ref-type="aff" rid="aff2">
						<sup>2</sup>
					</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dopazo</surname><given-names>Hernán</given-names></name><xref ref-type="aff" rid="aff1">
						<sup>1</sup>
					</xref><xref ref-type="corresp" rid="cor1">
						<sup>*</sup>
					</xref></contrib></contrib-group><aff id="aff1">
				<label>1</label>
				<addr-line> Pharmacogenomics and Comparative Genomics Unit, Centro de
					Investigación Príncipe Felipe (CIPF), Valencia, Spain
				</addr-line>
			</aff><aff id="aff2">
				<label>2</label>
				<addr-line> Functional Genomics Unit, Bioinformatics Department, Centro de
					Investigación Príncipe Felipe (CIPF), Valencia, Spain
				</addr-line>
			</aff><contrib-group><contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Hillis</surname><given-names>David</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Texas, United States of America</aff><author-notes><fn fn-type="con" id="ack1"><p>LA, JD, and HD conceived and designed the experiments. LA performed the
						experiments. LA and HD analyzed the data. LA, JD, and HD wrote the
					paper.</p></fn><corresp id="cor1">* To whom correspondence should be addressed. E-mail: <email xlink:type="simple">hdopazo@cipf.es</email></corresp><fn fn-type="conflict" id="ack3"><p> The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="ppub"><month>4</month><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>4</month><year>2006</year></pub-date><pub-date pub-type="epreprint"><day>15</day><month>3</month><year>2006</year></pub-date><volume>2</volume><issue>4</issue><elocation-id>e38</elocation-id><history><date date-type="received"><day>21</day><month>9</month><year>2005</year></date><date date-type="accepted"><day>15</day><month>3</month><year>2006</year></date></history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2006</copyright-year><copyright-holder>Arbiza et al</copyright-holder><license><license-p>This is an open-access article distributed under the
				terms of the Creative Commons Attribution License, which permits unrestricted use,
				distribution, and reproduction in any medium, provided the original author and
				source are credited.</license-p></license></permissions><abstract><p>For years evolutionary biologists have been interested in searching for the
					genetic bases underlying humanness. Recent efforts at a large or a complete
					genomic scale have been conducted to search for positively selected genes in
					human and in chimp. However, recently developed methods allowing for a more
					sensitive and controlled approach in the detection of positive selection can be
					employed. Here, using 13,198 genes, we have deduced the sets of genes involved
					in rate acceleration, positive selection, and relaxation of selective
					constraints in human, in chimp, and in their ancestral lineage since the
					divergence from murids. Significant deviations from the strict molecular clock
					were observed in 469 human and in 651 chimp genes. The more stringent
					branch-site test of positive selection detected 108 human and 577 chimp
					positively selected genes. An important proportion of the positively selected
					genes did not show a significant acceleration in rates, and similarly, many of
					the accelerated genes did not show significant signals of positive selection.
					Functional differentiation of genes under rate acceleration, positive selection,
					and relaxation was not statistically significant between human and chimp with
					the exception of terms related to <italic>G-protein coupled receptors</italic>
					and <italic>sensory perception</italic>. Both of these were over-represented
					under relaxation in human in relation to chimp. Comparing differences between
					derived and ancestral lineages, a more conspicuous change in trends seems to
					have favored positive selection in the human lineage. Since most of the
					positively selected genes are different under the same functional categories
					between these species, we suggest that the individual roles of the alternative
					positively selected genes may be an important factor underlying biological
					differences between these species.</p></abstract><abstract abstract-type="synopsis"><title>Synopsis</title><p>Since the publication of the human and the chimp genomes, one of the major
					challenges in evolutionary biology has begun to be deciphered: namely, the
					search for positively selected genes that have shaped humanness. Arbiza and
					colleagues undertake a genomic-scale search for the genes that have been
					positively selected in human, in chimp, and in their common ancestral lineage.
					They conclude that events of positive selection were six times more frequent in
					chimp than in human, although they do not group under specific functional
					classes that have been preferentially selected in either species. However, in
					the comparisons of the evolutionary trends between the ancestral and the
					descendant lineages, they found that most of the relative differences in common
					classes show an abundance of positive selection on the human branch. By
					differentiating positive selection from a relaxation of selective constraints,
					both producing analogous footprints in the genome, they demonstrate that many of
					the genes previously thought to have been positively selected correspond to
					likely cases of relaxation. Finally, they quantify the bias produced by the use
					of average rate–based approaches to concentrate cases of adaptive
					evolution in these species.</p></abstract><funding-group><funding-statement>LA is supported by Fundación la Caixa.</funding-statement></funding-group><counts><page-count count="13"/></counts><!--===== Restructure custom-meta-wrap to custom-meta-group =====--><custom-meta-group><custom-meta><meta-name>Citation:</meta-name><meta-value>Arbiza L, Dopazo J, Dopazo H (2006) Positive selection, relaxation,
						and acceleration in the evolution of the human and chimp genome. PLoS Comput
						Biol 2(4): e38. DOI: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.0020038" xlink:type="simple">10.1371/journal.pcbi.0020038</ext-link></meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>For years evolutionary biologists have been interested in knowing to what extent
				natural selection and genetic drift have shaped the genetic variation of populations
				and species [<xref ref-type="bibr" rid="pcbi-0020038-b001">1</xref>–<xref ref-type="bibr" rid="pcbi-0020038-b005">5</xref>]. Neutrality tests have provided powerful tools for developing
				hypotheses regarding this issue. The first objective of related studies had been to
				make general inferences about the causes of molecular evolution, and many efforts
				have been made to search for deviations from the molecular clock hypothesis.
				However, in the past ten years the focus has changed toward finding molecular events
				showing positive selection (PS) [<xref ref-type="bibr" rid="pcbi-0020038-b006">6</xref>].</p><p>PS is the process favoring the retention in a population of those mutations that are
				beneficial to the reproductive success of individuals. Contrary to this process, the
				molecular clock hypothesis [<xref ref-type="bibr" rid="pcbi-0020038-b007">7</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b008">8</xref>]
				postulates that the rate of evolution of molecular sequences is roughly constant
				over time. This observation has been taken as a strong evidence for the neutral
				mutation hypothesis [<xref ref-type="bibr" rid="pcbi-0020038-b003">3</xref>], which postulates that the majority of molecular changes in
				evolution are due to neutral or nearly neutral mutations [<xref ref-type="bibr" rid="pcbi-0020038-b002">2</xref>]. With the growing
				framework available for comparative genomic studies, it has been possible to test
				for neutrality against positive (or negative) selection at a genomic level.</p><p>Recent efforts at a large or genomic scale have been conducted to elucidate the
				intricacies of human evolution by means of comparing rate differences and PS against
				other fully sequenced species. In a recent work, Dorus et al. [<xref ref-type="bibr" rid="pcbi-0020038-b009">9</xref>] found significantly
				higher rates of gene evolution in the primate nervous system when comparing against
				housekeeping and among subsets of brain-specific genes. From this data they proposed
				natural selection as the underlying mechanism. Other efforts have focused on finding
				direct molecular evidence of PS. Clark et al. [<xref ref-type="bibr" rid="pcbi-0020038-b010">10</xref>], using more than 7,600 homologous
				sequences, found 1,547 human and 1,534 chimp genes as likely candidates to have been
				acted upon by PS. In a later study, Nielsen et al. [<xref ref-type="bibr" rid="pcbi-0020038-b011">11</xref>], using more than 13,000 orthologous
				sequences, found that 733 genes deviated from strict neutrality, showing evidences
				of PS. In the latest genomic study published as of the time of this writing, the
				Chimpanzee Sequencing and Analysis Consortium (CSAC) found 585 out of 13,454
				human–chimp orthologous genes as potential candidates to have been acted
				upon by PS, showing a Ka/Ki &gt; 1 [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>].</p><p>Indeed, while these three publications have been hallmarks in the genomic-scale
				search for events showing PS and have provided much insight into the subject, the
				combination of methods used have produced certain disagreements and have left some
				important considerations unaccounted for. As noted in the CSAC publication, the set
				of 585 genes observed may only be enriched for cases of PS given that, for example,
				the Ka/Ki statistic used could be &gt;1 by chance in almost half of these genes
				if purifying selection is allowed to act non uniformly [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>]. In Clark et al.
					[<xref ref-type="bibr" rid="pcbi-0020038-b010">10</xref>], the
				branch-site test used for PS allowed distinguishing of lineage-specific cases of
				selection in the branches of human and of chimp, which has been criticized by other
				authors given that it may have suffered from the inclusion of false positives
				originating from the lack of power of the test to distinguish true cases of PS from
				cases of relaxation of selective constraints (RSC) [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b013">13</xref>]. The study by Nielsen et al. [<xref ref-type="bibr" rid="pcbi-0020038-b011">11</xref>], with the exception
				of a small subset of 50 analyzed genes, was based on pair-wise comparisons that make
				it impossible to know in which of these lineages selection has occurred. In
				addition, in all of these studies, differentiation of the sets of genes under PS
				from the sets that are likely cases of RSC has not been done nor used specifically
				for study.</p><p>Finally, it is important to note that likelihood ratio tests like those used here and
				in some previous studies are sensitive to model assumptions [<xref ref-type="bibr" rid="pcbi-0020038-b013">13</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>]. While the tests used in this study
				have been shown to have a good performance under a variety of conditions
					[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>], we
				prefer to address the definition of a genomic set of genes under PS from a
				conservative standpoint. Thus, while some of these studies have considered multiple
				testing corrections only for case-specific observations after comparisons, we have
				taken the approach of employing corrections for multiple testing as the norm for all
				comparisons, while considering the uncorrected sets for confirmation of specific
				results where appropriate.</p><p>Therefore many important questions regarding the identity and functional roles of
				genes showing acceleration, RSC, and PS, still remain: which are the genes that can
				be assigned to these sets with a considerable degree of sensitivity and confidence?
				Are these genes significantly different between species in functional terms? Do
				these genes encompass a special group of functional classes, or are they an unbiased
				representation of the genome? To what extent do the set of positively selected genes
				(PSG) differ from the set of accelerated genes? How many of the PSG can be
				distinguished from cases of RSC? Furthermore, can we gain any additional insight by
				comparing the pattern of adaptation of the derived species against that in their
				ancestral lineage?</p><p>All of these questions can only be answered by testing for deviations from the
				neutral theory in human, in chimp, and in their common ancestor, independently,
				using sensitive tests for PS while correcting for multiple testing. In this study,
				we have searched for the most complete set of known human genes with the chimp,
				mouse, rat, and dog orthologs available in order to answer all of these questions.</p><p>The two branch-site maximum likelihood (ML) tests of PS employed in this paper
				benefit from a high degree of sensitivity when compared with previous branch tests,
				and can be used together, as has been recently shown [<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>], in an approach that allows
				detecting lineage-specific events while distinguishing true cases of PS from likely
				cases of RSC. Both these tests are based on the comparison of the likelihood with
				which two alternative models fit sequence data. Test I compares the nearly neutral
				null model (M1a) against the alternative PS model (A). M1a assumes two codon site
				classes evolving under purifying selection and neutral evolution in all the lineages
				of the phylogeny. Model A considers two additional site classes conserved or
				evolving neutrally on all the branches (background lineages), except on a specified
				branch where PS is tested for (the foreground lineage). Test II compares the null
				model (A1) against the alternative model A. Parameters in model A1 are equal to
				those of model A with the exception that the two additional site classes in the
				foreground are only allowed to evolve neutrally. As was demonstrated by Zhang et al.
					[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>],
				Test I cannot suitably distinguish cases of RSC from true events of PS, while Test
				II is able to make this distinction. One can therefore compare between the results
				of both tests in order to distinguish cases of PS from likely cases of RSC.</p><p>This is the first comparative genomic study where the lineage-specific events
				involved in processes of PS and RSC occurring in the human genome before and after
				the speciation event that differentiated us from our closest living species have
				been deduced.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Testing the Molecular Clock Hypothesis</title><sec id="s2a1"><title>Relative rates test.</title><p>The analysis begins with the complete set of 30,709 genes in the Ensembl
						Human Database version 30.35c. These were filtered to remove all genes that
						had not been confirmed through mapping to Swiss-Prot, RefSeq, or SPTreEMBL,
						and a total of 20,469 genes, which in this manner had acquired the Ensembl
						known gene status, remained. Inspection of ortholog annotations for this set
						of genes in the Ensembl-Compara database (version 30) yielded 14,185 human
						genes with ortholog predictions in chimp, mouse, rat, and dog, corresponding
						to 69% of the known Ensembl human genome. After filtering the
						sequences by length and exceedingly high evolutionary rates, 13,197 genes
						were analysed by means of the relative rates test (RRT) (see <xref ref-type="supplementary-material" rid="pcbi-0020038-st001">Table
						S1</xref>). Evolutionary differences in rates between human and chimp were
						evaluated using Ka and Ks rates (Ka-RRT, Ks-RRT). Rate saturation was
						observed for 959 (7.3%) genes. After the RRT analysis,
						significant deviations from the molecular clock were observed for 844
						(6.4%) human genes and for 1,260 (9.5%) chimp genes.
						After correcting for multiple testing (<italic>p</italic> &lt; 0.05),
						the number of genes retained for further statistical analysis were 469 in
						human and 651 in chimp.</p><p>A more detailed analysis showed significant deviations in both Ka and Ks
						tests for 65 (0.5%) genes, out of which 18 evolved relatively
						faster in human than in chimp (HF), and 47 evolved relatively faster in
						chimp than in human (ChF). It is important to note that HF and ChF terms
						represent relative, rather than absolute, rate definitions. The number of
						genes for which there were significant differences, in either only Ka or
						only Ks, was higher for chimp (477 and 99) than for human (352 and 83),
						respectively. The RRT performed showed that a higher number of genes have
						significantly accelerated in nonsynonymous (938) rather than in synonymous
						changes (247). The ratio of the number of genes showing an acceleration of
						nonsynonymous to synonymous rates was similar and more than threefold
						(approximately 3.8) in both species. This bias constitutes an indirect
						evidence of the already characterized overdispersed clock in mammals, which
						suggests that protein evolution cannot be explained by a simple model theory
						of neutral evolution [<xref ref-type="bibr" rid="pcbi-0020038-b001">1</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b015">15</xref>].</p></sec><sec id="s2a2"><title>Rate differences in genes and species.</title><p><xref ref-type="table" rid="pcbi-0020038-t001">Table 1</xref> shows the mean
						values obtained from RRT in the group of genes with significant deviations
						from the molecular clock hypothesis. They are arranged according to
						mutational changes (Ka and Ks), three ranges of <italic>p</italic>-values
						adjusted for multiple testing, and the two alternative directions of
						acceleration (HF or ChF).</p><table-wrap content-type="1col" id="pcbi-0020038-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.t001</object-id><label>Table 1</label><caption><p>RRT Results</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.t001" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb1col1" align="left" charoff="0" char=""/><col id="tb1col2" align="char" charoff="0" char="."/><col id="tb1col3" align="char" charoff="0" char="."/><col id="tb1col4" align="char" charoff="0" char="."/><col id="tb1col5" align="char" charoff="0" char="."/><col id="tb1col6" align="char" charoff="0" char="."/><col id="tb1col7" align="left" charoff="0" char=""/><col id="tb1col8" align="char" charoff="0" char="."/><col id="tb1col9" align="char" charoff="0" char="."/><col id="tb1col10" align="char" charoff="0" char="."/><col id="tb1col11" align="char" charoff="0" char="."/><col id="tb1col12" align="char" charoff="0" char="."/><col id="tb1col13" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Acceleration</td><td><hr/>Ka</td><td><hr/>dKa</td><td><hr/>rKa</td><td><hr/>Na</td><td><hr/>Percent</td><td><hr/><italic>p</italic><sub>r</sub></td><td><hr/>Ks</td><td><hr/>dKs</td><td><hr/>rKs</td><td><hr/>Ns</td><td><hr/>Percent</td><td><hr/><italic>p</italic><sub>r</sub></td></tr></thead><tbody><tr><td>HF</td><td>0.069</td><td>5.0E-04</td><td>3.067</td><td>57</td><td>14.77</td><td>Low</td><td>0.498</td><td>5.1E-02</td><td>3.180</td><td>25</td><td>24.75</td><td>Low</td></tr><tr><td></td><td>0.064</td><td>0.008</td><td>3.661<sup>a</sup></td><td>48</td><td>12.43</td><td>Medium</td><td>0.394</td><td>0.031</td><td>3.772</td><td>21</td><td>20.79</td><td>Medium</td></tr><tr><td></td><td>0.083</td><td>0.007</td><td>9.71<sup>b</sup></td><td>281</td><td>72.80</td><td>High</td><td>0.426</td><td>0.034</td><td>5.855</td><td>55</td><td>54.46</td><td>High</td></tr><tr><td>ChF</td><td>0.059</td><td>7.7E-03</td><td>3.077</td><td>114</td><td>20.65</td><td>Low</td><td>0.523</td><td>7.1E-02</td><td>3.248<sup>c</sup></td><td>35</td><td>23.97</td><td>Low</td></tr><tr><td></td><td>0.070</td><td>0.012</td><td>3.607</td><td>63</td><td>11.41</td><td>Medium</td><td>0.431</td><td>0.034</td><td>3.748</td><td>27</td><td>18.49</td><td>Medium</td></tr><tr><td></td><td>0.101</td><td>0.019</td><td>9.919<sup>b</sup></td><td>375</td><td>67.94</td><td>High</td><td>0.461</td><td>0.078</td><td>5.796</td><td>84</td><td>57.54</td><td>High</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt101"><p>Evolutionary rate of genes with significant deviations from the molecular clock hypothesis.</p></fn><fn id="nt102"><p>Accelerated human (HF) and chimp (ChF) genes are arranged according to three ranges of significance (<italic>p</italic><sub>r</sub>) of the RRT.</p></fn><fn id="nt103"><p>p<sub>r</sub>, low, medium, and high correspond to adjusted <italic>p</italic>-values in the ranges 0.01 &lt; <italic>p</italic> &le; 0.05, 0.001 &lt; <italic>p</italic> &le; 0.01, and <italic>p</italic> &le; 0.001, respectively.</p></fn><fn id="nt104"><p>K<sub>i</sub> is the mean evolutionary rate value measured in substitutions per site. dKi (Ki<sub>h</sub>&minus;Ki<sub>ch</sub>) is the mean rate difference between species. rKi is the mean normalized difference in rates (Ki<sub>h</sub>/sdi<sub>h</sub>&minus;Ki<sub>ch</sub>/sdi<sub>ch</sub>), where sd is the standard deviation.</p></fn><fn id="nt105"><p>Ni is the number of genes analyzed where subscript i is s (synonymous) or a (nonsynonymous), respectively.</p></fn><fn id="nt106"><p><sup>a</sup>The value was significantly higher than that observed in chimp (<italic>p</italic> &lt; 0.05, K-S test).</p></fn><fn id="nt107"><p><sup>b</sup>The values were influenced by outliers. If median, instead of mean, values were calculated, 8.63 and 8.34 are obtained for ChF and HF, respectively.</p></fn><fn id="nt109"><p><sup>c</sup>The value was significantly higher than that observed in human (<italic>p</italic> &lt; 0.05, K-S test).</p></fn></table-wrap-foot> --></table-wrap><p>The bulk of all genes fall within the category showing the highest rates of
						evolution changing by nonsynonymous mutations (<italic>p</italic> &lt;
						0.001, <italic>p</italic><sub>r</sub> = high in <xref ref-type="table" rid="pcbi-0020038-t001">Table 1</xref>), suggesting a
						favorable scenario for the presence of PS in human and in chimp. The
						Kolmogorov–Smirnov (K–S) test performed on mean
						normalized differences in rates (rKi in <xref ref-type="table" rid="pcbi-0020038-t001">Table 1</xref>) detected significant differences
						in the medium rKa category, favoring human, and in the low rKs category,
						favoring chimp (<italic>p</italic> &lt; 0.05). These minor differences
						were not sufficient to produce a net significant difference when comparing
						the full sets of genes without clock-like behavior in both species.</p><p><xref ref-type="table" rid="pcbi-0020038-t002">Table 2</xref> shows the mean
						evolutionary rates estimated for human and for chimp using a topologically
						weighted outgroup, with mouse, rat, and dog as the reference in two
						alternative datasets. On the one hand, using only the group of genes showing
						significant RRT differences, the mean estimation of the human nonsynonymous
						rate of evolution (Ka = 0.079) was slower than that of chimp (Ka
						= 0.088), although the difference was not significant
						(<italic>p</italic> = 0.13). The same occurred for the synonymous
						rate change (<italic>p</italic> = 0.24). The relative
						evolutionary rate of chimp to human (R on <xref ref-type="table" rid="pcbi-0020038-t002">Table 2</xref>) was 1.11 for Ka and 1.08 for Ks.
						On the other hand, when considering the full set of filtered orthologous
						genes, mean rates in substitutions per site were Ka = 0.086 and
						Ks = 0.430 for human, and Ka = 0.087 and Ks
						= 0.432 for chimp. Rate differences for Ka and Ks between species
						were again not significant. The mean Ka/Ks rate was similar between species
						and was slightly higher for the set of genes representing the complete
						genome than for those showing significant deviations from clock behavior
						(0.20 versus 0.18). This is due to the relative increase of the mean Ks rate
						observed on genes with significant deviations from clock (<xref ref-type="table" rid="pcbi-0020038-t002">Table 2</xref>).</p><table-wrap content-type="1col" id="pcbi-0020038-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.t002</object-id><label>Table 2</label><caption><p>Evolutionary Rates of Human and of Chimp</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.t002" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb2col1" align="left" charoff="0" char=""/><col id="tb2col2" align="left" charoff="0" char=""/><col id="tb2col3" align="left" charoff="0" char=""/><col id="tb2col4" align="left" charoff="0" char=""/><col id="tb2col5" align="left" charoff="0" char=""/><col id="tb2col6" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left"><hr/>Datasets</td><td><hr/>Parameter</td><td><hr/>Human</td><td><hr/>Chimp</td><td><hr/>R</td><td><hr/><italic>p</italic></td></tr></thead><tbody><tr><td>RRT significant</td><td valign="middle">Ka</td><td valign="middle">0.079</td><td valign="middle">0.088</td><td valign="middle">1.11</td><td valign="middle">0.13</td></tr><tr><td></td><td valign="middle">sd</td><td valign="middle">0.088</td><td valign="middle">0.094</td><td valign="middle"></td><td valign="middle"></td></tr><tr><td></td><td valign="middle">Ks</td><td valign="middle">0.437</td><td valign="middle">0.470</td><td valign="middle">1.08</td><td valign="middle">0.24</td></tr><tr><td></td><td valign="middle">sd</td><td valign="middle">0.160</td><td valign="middle">0.165</td><td valign="middle"></td><td valign="middle"></td></tr><tr><td></td><td valign="middle">Ka/Ks</td><td valign="middle">0.181</td><td valign="middle">0.187</td><td valign="middle">1.03</td><td valign="middle"></td></tr><tr><td>Genome<sup>a</sup></td><td valign="middle">Ka</td><td valign="middle">0.086</td><td valign="middle">0.087</td><td valign="middle">1.01</td><td valign="middle">0.77</td></tr><tr><td></td><td valign="middle">sd</td><td valign="middle">0.156</td><td valign="middle">0.156</td><td valign="middle"></td><td valign="middle"></td></tr><tr><td></td><td valign="middle">Ks</td><td valign="middle">0.430</td><td valign="middle">0.432</td><td valign="middle">1.00</td><td valign="middle">0.83</td></tr><tr><td></td><td valign="middle">sd</td><td valign="middle">0.196</td><td valign="middle">0.196</td><td valign="middle"></td><td valign="middle"></td></tr><tr><td></td><td valign="middle">Ka/Ks</td><td valign="middle">0.200</td><td valign="middle">0.201</td><td valign="middle">1.01</td><td valign="middle"></td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt201"><p>Ka and Ks for human and for chimpanzee were estimated using mouse, rat, and dog as a weighted outgroup. Results for the set of genes evolving by significant differences in RRT and for the complete genome<sup>a</sup> are shown.</p></fn><fn id="nt202"><p>Human and Chimp columns hold the mean number of substitutions per site.</p></fn><fn id="nt203"><p>R is the mean relative evolutionary rates ratio of chimp to human.</p></fn><fn id="nt204"><p><italic>p</italic> Corresponds to the two sample K-S test probability value under Ho: Ki<sub>h</sub>&minus;Ki<sub>ch</sub> &equals; 0, where i is a or s, respectively.</p></fn><fn id="nt205"><p>sd (Standard deviations) are shown below each estimate.</p></fn><fn id="nt206"><p><sup>a</sup>Genome represents the full set of 13,197 filtered orthologous gene alignments.</p></fn></table-wrap-foot> --></table-wrap><p>ML estimations of evolutionary rates in the human branch and in the chimp
						branch were calculated using PAML [<xref ref-type="bibr" rid="pcbi-0020038-b016">16</xref>] and compared with those
						recently obtained by the CSAC [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>]. While our estimations were
						slightly faster for human (Ka = 0.0014, Ks = 0.0063
						versus CSAC: Ka = 0.0013, Ks = 0.0062) and for chimp
						(Ka = 0.0015, Ks = 0.0066 versus CSAC: Ka =
						0.0012, Ks = 0.0060), they were considerably similar to those
						obtained by the CSAC using a highly curated set of 7,043 orthologous genes
							[<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>]. The total number of genes with Ka/Ks &gt; 1 was
						445 in human and 539 in chimp, representing 5% and 6%
						of the total number of genes with a measurable ML estimation of the rates
						ratio, respectively.</p></sec><sec id="s2a3"><title>Functional analysis of accelerated genes in human and in chimp.</title><p>Using human Gene Ontology (GO) terms [<xref ref-type="bibr" rid="pcbi-0020038-b017">17</xref>], we have focused on seeing
						if there are any functional differences in the set of genes accelerated
						within the human genome and between both lineages. GO terms for chimpanzee
						were deduced from the corresponding human orthologs.</p><p><xref ref-type="table" rid="pcbi-0020038-t003">Table 3</xref> shows the main
						GO terms corresponding to biological processes at GO level 6 associated to
						human and to chimp genes accelerated in synonymous and nonsynonymous
						changes. The most significant terms in the analysis of Ka and Ks are shown.
						The table is arranged according to those terms represented above
						5% in the set of human nonsynonymous accelerated genes (column
						1). Other terms above 5%, not shown in the table, were indeed
						observed in other categories (see <xref ref-type="supplementary-material" rid="pcbi-0020038-sd001">Dataset S1</xref> for a complete list of
						terms). For instance, <italic>cation transport</italic> (6.78%)
						was observed in the list of genes with coding sequences evolving faster in
						chimp than in human by means of nonsynonymous changes. Other terms such as
							<italic>RNA metabolism, DNA metabolism, regulation of protein
							metabolism, regulation of programmed cell death, protein
						catabolism,</italic> and <italic>cellular carbohydrate metabolism</italic>
						correspond to some of the human sequences and the chimp sequences
						accelerated by synonymous changes above 5%.</p><table-wrap content-type="1col" id="pcbi-0020038-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.t003</object-id><label>Table 3</label><caption><p>Functional Analysis of Genes with Deviations from the Molecular
							Clock</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.t003" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb3col1" align="left" charoff="0" char=""/><col id="tb3col2" align="char" charoff="0" char="."/><col id="tb3col3" align="char" charoff="0" char="."/><col id="tb3col4" align="char" charoff="0" char="."/><col id="tb3col5" align="char" charoff="0" char="."/><col id="tb3col6" align="char" charoff="0" char="."/><col id="tb3col7" align="char" charoff="0" char="."/></colgroup><thead><tr><td align="left" rowspan="2"><hr/>GO Term</td><td colspan="3"><hr/>Ka</td><td colspan="3"><hr/>Ks</td></tr><tr><td><hr/>HF</td><td><hr/>ChF</td><td><hr/><italic>p</italic></td><td><hr/>HF</td><td><hr/>ChF</td><td><hr/><italic>p</italic></td></tr></thead><tbody><tr><td valign="middle">Cellular protein metabolism</td><td>34.31 (82)</td><td>30.68 (104)</td><td>1</td><td>21.67 (13)</td><td>29.73 (22)</td><td>1</td></tr><tr><td valign="middle">Transcription</td><td>22.18 (57)</td><td>21.83 (79)</td><td>1</td><td>18.33 (11)</td><td>18.92 (14)</td><td>1</td></tr><tr><td valign="middle">Regulation of transcription</td><td>20.43 (53)</td><td>19.17 (74)</td><td>1</td><td>16.67 (10)</td><td>18.92 (14)</td><td>1</td></tr><tr><td valign="middle">Regulation of nucleobase<sup>a</sup></td><td>22.18 (53)</td><td>22.12 (75)</td><td>1</td><td>16.67 (10)</td><td>18.92 (14)</td><td>1</td></tr><tr><td valign="middle">Phosphate metabolism</td><td>9.62 (23)</td><td>9.14 (31)</td><td>1</td><td>5.00 (3)</td><td>4.05 (3)</td><td>1</td></tr><tr><td valign="middle">Cellular macromolecule catabolism</td><td>9.62 (23)</td><td>7.67 (26)</td><td>1</td><td>5.00 (3)</td><td>8.11 (6)</td><td>1</td></tr><tr><td valign="middle">Macromolecule biosynthesis</td><td>8.37 (20)</td><td>4.72 (16)</td><td>1</td><td>6.67 (4)</td><td>6.76 (5)</td><td>1</td></tr><tr><td valign="middle">Protein catabolism</td><td>7.53 (18)</td><td>6.78 (23)</td><td>1</td><td>3.33 (2)</td><td>8.11 (6)</td><td>1</td></tr><tr><td valign="middle">Protein biosynthesis</td><td>7.53 (18)</td><td>4.72 (16)</td><td>1</td><td>6.67 (4)</td><td>6.76 (5)</td><td>1</td></tr><tr><td valign="middle">Apoptosis</td><td>7.11 (17)</td><td>4.72 (16)</td><td>1</td><td>1.67 (1)</td><td>8.11 (6)</td><td>1</td></tr><tr><td valign="middle">Protein transport</td><td>6.69 (16)</td><td>5.90 (20)</td><td>1</td><td>5.00 (3)</td><td>2.70 (2)</td><td>1</td></tr><tr><td valign="middle">DNA metabolism</td><td>6.69 (16)</td><td>5.01 (17)</td><td>1</td><td>6.67 (4)</td><td>2.70 (2)</td><td>1</td></tr><tr><td valign="middle">Immune response</td><td>6.28 (15)</td><td>6.78 (23)</td><td>1</td><td>11.67 (7)</td><td>10.81 (8)</td><td>1</td></tr><tr><td valign="middle">RNA metabolism</td><td>6.28 (15)</td><td>4.13 (14)</td><td>1</td><td>1.67 (1)</td><td>8.11 (6)</td><td>1</td></tr><tr><td valign="middle">Cytoskeleton organization &amp; biogenesis</td><td>5.44 (13)</td><td>4.72 (16)</td><td>1</td><td>1.67 (1)</td><td>1.35 (1)</td><td>1</td></tr><tr><td valign="middle">Total number of genes</td><td>386</td><td>552</td><td></td><td>101</td><td>146</td><td></td></tr><tr><td valign="middle">Genes with GO terms at level 6</td><td>239</td><td>339</td><td></td><td>60</td><td>74</td><td></td></tr><tr><td valign="middle">Genes with GO terms at other levels</td><td>100</td><td>125</td><td></td><td>20</td><td>38</td><td></td></tr><tr><td valign="middle">Genes without GO terms</td><td>47</td><td>88</td><td></td><td>21</td><td>34</td><td></td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt301"><p>HF and ChF column values are percentages of the total genes with GO at level 6.</p></fn><fn id="nt302"><p>Parentheses enclose the number of genes for each term.</p></fn><fn id="nt303"><p>The list of genes accelerated in human (HF) were used as the query list, while those accelerated in chimp (ChF) were used as the reference for the statistical analysis. Terms were arranged according to a decreasing percent-representation within the subset of HF-KA above 5&percnt;.</p></fn><fn id="nt304"><p><sup>a</sup>Regulation of nucleobase, nucleoside, nucleotide, and nucleic acid metabolism.</p></fn></table-wrap-foot> --></table-wrap><p>To find out if there were any over- or under-represented GO terms in between
						human and chimp, a Fisher exact test with <italic>p</italic>-values
						corrected for multiple testing was run using FatiGO [<xref ref-type="bibr" rid="pcbi-0020038-b018">18</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b019">19</xref>]. Neither the test applied on
						HF and ChF genes with coding sequences evolving by means of nonsynonymous
						changes, nor that for synonymous ones, reported any significant difference
						for GO-term representation at any level (GO levels 3–6). We
						conclude that there are no statistically significant differences in
						functional GO classes represented in the sets of the genes without
						clock-like behavior between the two species. Finally, we tested the
						hypothesis that accelerated human genes represent an unbiased sample of the
						human genome in functional terms. Again, no GO terms were found to be
						significantly over- or under-represented among accelerated human genes when
						compared with the rest of the genome.</p><p>In summary, we have not detected GO terms differentially distributed between
						the significantly accelerated genes of human and of chimp. Moreover, the set
						of functions accelerated in human does not represent a special subset of
						genes with functional particularities within the human genome.</p></sec><sec id="s2b"><title>Testing adaptation in human and in chimp lineages.</title><p>The set of genes used for clock testing were also analyzed for signals of PS.
						After discarding those with fewer than three unique base pair differences,
						9,674 human–chimp–mouse–rat–dog
						orthologous sequences remained. This set was then analyzed for signals of PS
						with Tests I and II, which can be used to distinguish RSC from true events
						of PS when used in conjunction with each other [<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>]. Both tests
						were performed on human and on chimp lineages, and 146 (1.51%)
						human and 672 (6.95%) chimp genes were obtained when the more
						restrictive Test II was considered. After correcting for multiple testing
							(<italic>p</italic> &lt; 0.05), 108 (1.12%) and 577
						(5.96%) genes in human and in chimp remained and were considered
						as true cases of PS occurring in their respective genomes.</p></sec><sec id="s2b1"><title>Functional analysis of PSG.</title><p><xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> shows the main
						GO terms associated to the set of PSG detected using Test II in human and in
						chimp, as well as the difference in representation of GO terms for the sets
						of genes under PS for both species when compared with their ancestral
						lineage (see <xref ref-type="supplementary-material" rid="pcbi-0020038-sd001">Dataset S1</xref> for a complete list of
						terms). As before, terms shown are those represented above 5% in
						human PSG (H-PSG).</p><table-wrap content-type="1col" id="pcbi-0020038-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.t004</object-id><label>Table 4</label><caption><p>Functional Analysis of PSG</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.t004" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb4col1" align="left" charoff="0" char=""/><col id="tb4col2" align="char" charoff="0" char="."/><col id="tb4col3" align="char" charoff="0" char="."/><col id="tb4col4" align="char" charoff="0" char="."/><col id="tb4col5" align="char" charoff="0" char="."/><col id="tb4col6" align="char" charoff="0" char="."/></colgroup><thead><tr><td align="left" rowspan="2"><hr/>GO Term</td><td colspan="5"><hr/>Adaptive Evolution</td></tr><tr><td><hr/>H</td><td><hr/>Ch</td><td><hr/>N<sub>o</sub></td><td><hr/>H-AH</td><td><hr/>Ch-AH</td></tr></thead><tbody><tr><td>Cellular protein metabolism</td><td>16.67 (7)</td><td>31.00 (102)</td><td>3</td><td><bold>&minus;10.68</bold></td><td><bold>&plus;1.66</bold></td></tr><tr><td>G-protein coupled receptor<sup>a</sup></td><td>21.43 (9)</td><td>6.08 (20)</td><td>0</td><td><bold>&plus;8.33</bold></td><td><bold>&minus;4.56</bold></td></tr><tr><td>Sensory perception</td><td>16.67 (7)</td><td>3.65 (12)</td><td>0</td><td><bold>&plus;9.37</bold></td><td><bold>&minus;1.66</bold></td></tr><tr><td>Regulation of nucleobase<sup>b</sup></td><td>11.90 (5)</td><td>14.29 (47)</td><td>0</td><td><bold>&minus;3.12</bold></td><td><bold>&plus;0.49</bold></td></tr><tr><td>Transcription</td><td>11.90 (5)</td><td>15.20 (50)</td><td>0</td><td><bold>&minus;4.42</bold></td><td><bold>&plus;0.08</bold></td></tr><tr><td>Regulation of transcription</td><td>11.90 (5)</td><td>13.98 (46)</td><td>0</td><td><bold>&minus;2.86</bold></td><td><bold>&plus;0.45</bold></td></tr><tr><td>Cellular macromolecule catabolism</td><td>9.52 (4)</td><td>9.42 (31)</td><td>1</td><td>&plus;2.09</td><td>&plus;1.27</td></tr><tr><td>Immune response</td><td>9.52 (4)</td><td>4.86 (16)</td><td>0</td><td>&minus;1.57</td><td>&minus;5.31</td></tr><tr><td>Protein transport</td><td>7.14 (3)</td><td>4.86 (16)</td><td>1</td><td>&plus;4.16</td><td>&plus;0.96</td></tr><tr><td>Protein catabolism</td><td>7.14 (3)</td><td>8.81 (29)</td><td>1</td><td>&plus;1.30</td><td>&plus;1.99</td></tr><tr><td>Intracellular protein transport</td><td>7.14 (3)</td><td>3.95 (13)</td><td>1</td><td>&plus;5.73</td><td>&plus;1.64</td></tr><tr><td>Cytoskeleton organization and biogenesis</td><td>4.76 (2)</td><td>4.86 (16)</td><td>2</td><td>&plus;4.68</td><td>&plus;1.81</td></tr><tr><td>Phosphate metabolism</td><td>7.14 (3)</td><td>7.90 (26)</td><td>0</td><td>&minus;5.21</td><td>&minus;2.06</td></tr><tr><td>Cellular carbohydrate metabolism</td><td>4.76 (2)</td><td>2.74 (9)</td><td>1</td><td><bold>&plus;2.08</bold></td><td><bold>&minus;1.24</bold></td></tr><tr><td>Response to pest, pathogen, or parasite</td><td>7.14 (3)</td><td>2.43 (8)</td><td>0</td><td>&minus;1.82</td><td>&minus;4.05</td></tr><tr><td>DNA metabolism</td><td>4.76 (2)</td><td>6.08 (20)</td><td>1</td><td>&plus;0.52</td><td>&plus;0.59</td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt401"><p>H and Ch column values are percentages of the total genes with GO at level 6.</p></fn><fn id="nt402"><p>Parentheses enclose numbers that represent H-PSG and Ch-PSG selected exclusively in each lineage.</p></fn><fn id="nt403"><p>Terms were arranged according to the decreasing percent-representation observed within the subset of H-PSG above a 5&percnt; frequency. Percentages exclude common orthologous genes selected in both lineages (N<sub>o</sub>).</p></fn><fn id="nt404"><p>H-AH and Ch-AH represent the differences in GO representation between derived and ancestral lineages (AH, ancestral hominid lineage). Positive and negative values show an increase or a decrease in relation to the ancestor, respectively.</p></fn><fn id="nt405"><p>Bolded numbers show opposite trends occurring in the derived lineages.</p></fn><fn id="nt406"><p>Query and reference groups, <italic>p,</italic> are as in <xref ref-type="table" rid="pcbi-0020038-t003">Table 3</xref>.</p></fn><fn id="nt407"><p><sup>a</sup>G-protein coupled receptor protein signalling pathway.</p></fn><fn id="nt408"><p><sup>b</sup>Regulation of nucleobase, nucleoside, nucleotide, and nucleic acid metabolism.</p></fn></table-wrap-foot> --></table-wrap><p>Initially, when comparing representations of terms under human and chimp
						directly, it is evident that with minor modifications of frequencies H-PSG
						have shown almost the same set of biological functions as those in chimp
						(Ch-PSG). It is interesting to note that in this comparison the highest
						differences in representation of genes between both lineages are found under
						terms such as <italic>G-protein coupled receptor</italic> (GPCR),
							<italic>sensory perception, electron transport, integrin-mediated
							signalling pathway, inflammatory response,</italic> and <italic>cellular
							protein metabolism,</italic> among others. All of these terms were
						represented to a greater extent in human with the exception of
							<italic>cellular protein metabolism,</italic> which was higher in chimp.
						Although the highest differences range from 4% to 15%,
						they were nonsignificant at any level (GO levels 3–6). Likewise,
						no term was significantly over- or under-represented in the comparison of
						H-PSG against the rest of the human genome. However, it is important to note
						that at least one difference seems evident: only a minor number of
						orthologous PSG are common between both species (N<sub>o</sub> column in
							<xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref>). This
						shows that PS-driven evolution of different genes under the same functional
						classes is the most frequent pattern occurring after speciation.</p><p>A more striking difference becomes noticeable when switching from the
						perspective of a direct comparison of the functional GO categories under PS
						for human and for chimp, to that based on the relative differences observed
						between the ancestral lineage and each one of the corresponding derived
						species. The H-AH and Ch-AH columns in <xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> show the difference in
						representation of GO categories between the derived and ancestral lineages
						for human and for chimp, respectively. The representation of PSG under
							<italic>G-protein coupled receptor, sensory perception,</italic> and
							<italic>cellular carbohydrate metabolism</italic>, increase (+
						values) in the human lineage while decreasing (− values) in chimp
						when compared with the ancestral lineage. In a similar but opposite manner,
						terms such as <italic>cellular protein metabolism, transcription</italic>
						and its regulation, <italic>regulation of nucleobase, nucleoside, and
							nucleotide metabolism,</italic> and <italic>cellular carbohydrate
							metabolism</italic> show a relative increase in chimp while decreasing
						in human. From this perspective, we can observe differences that could not
						be discerned from a direct comparison between derived lineages only: some
						terms have increased or decreased in relation to the ancestor in both
						species, others have changed in opposite directions in human and in chimp.
						The greatest relative differences observed (&gt;10% between
						H-AH and Ch-AH) in the distribution of functional categories under PS
						correspond only to three categories: <italic>cellular protein
						metabolism</italic> which was comparatively favored by natural selection in
						chimp, and <italic>G-coupled protein receptor signalling pathway</italic>
						and <italic>sensory perception,</italic> comparatively favored in human.
						Finally, the relative differences observed in the remaining GO categories in
							<xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> were below
						5%.</p></sec></sec><sec id="s2c"><title>PS and Nonsynonymous Rate Acceleration</title><p>It is held that genes showing acceleration in nonsynonymous rate are likely to
					concentrate cases of PS. However, the comparison of <xref ref-type="table" rid="pcbi-0020038-t003">Tables 3</xref> and <xref ref-type="table" rid="pcbi-0020038-t004">4</xref> reveals an outstanding difference between
					most of the represented GO categories under both processes. While four of the GO
					categories, each containing more than 50 genes with a significant nonsynonymous
					rate acceleration (<xref ref-type="table" rid="pcbi-0020038-t003">Table
					3</xref>), are within those most highly represented under PS in both species
						(<xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref>), the terms
						<italic>G-coupled protein receptor signalling pathway</italic> and
						<italic>sensory perception</italic> were absent among those showing a
					significant acceleration in nonsynonymous rates. To understand these and other
					major discrepancies in the number of positives observed in Ka
					rate–based approaches and Test II, the relationship between the
					nonsynonymous rates difference (dKa =
						Ka<sub>h</sub>−Ka<sub>ch</sub>), the mean normalized differences
					in nonsynonymous rates between the species (rKa = dKa/sd), and the
					normalized nonsynonymous rate (Ka/Ks), were studied.</p><p><xref ref-type="fig" rid="pcbi-0020038-g001">Figure 1</xref> shows the
					distribution of rKa versus dKa values for those genes with significant and
					nonsignificant differences in Ka-RRT (“molecular clock” in
						<xref ref-type="fig" rid="pcbi-0020038-g001">Figure 1</xref>). Under this
					distribution, four alternative groups have been labeled: those showing 1) both
					PS and Ka/Ks &gt; 1 (red circles), 2) PS and Ka/Ks &lt; 1 (blue
					circles), 3) Ka/Ks &gt; 1 with no evidence of PS (black asterisks), and 4)
					Ka/Ks &lt; 1 with no evidence of PS (grey circles).</p><fig id="pcbi-0020038-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.g001</object-id><label>Figure 1</label><caption><title>PS and Rates of Evolution</title><p>A minor proportion of genes with Ka/Ks &gt; 1 match events of PS in
							human and in chimp (red circles). Many of the genes with Ka/Ks &lt;
							1 show evidence of PS (blue circles). Genes with Ka/Ks &gt; 1
							without evidence of PS (black asterisks) fall mostly under molecular
							clock conditions for nonsynonymous changes (circles below the broken red
							line). Most of the genes without evidence of PS and Ka/Ks &lt; 1
							(grey circles) are scattered below the boundary limiting molecular clock
							like behavior and are observed at dKa &lt; 0.0006 when molecular
							clock conditions are not fulfilled. Genes outside of clock conditions
							and dKa &gt; 0.0006 coincide mostly with events of PS in both of the
							species (red and blue circles above the broken line). dKa and rKa as
							defined in <xref ref-type="table" rid="pcbi-0020038-t001">Table
							1</xref>.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.g001" xlink:type="simple"/></fig><p>The total number of genes with Ka/Ks &gt; 1 considered in the analysis of
						<xref ref-type="fig" rid="pcbi-0020038-g001">Figure 1</xref> was 336 in
					human (437 in chimp), out of which 22 (86) have shown evidence of PS (red
					circles in <xref ref-type="fig" rid="pcbi-0020038-g001">Figure 1</xref>) and
					only five (18) have shown significant deviations from the molecular clock in Ka
					rate (circles above the broken line). Alternatively, 58 human (407 chimp) genes
					with Ka/Ks &lt; 1 were positively selected (blue circles). This shows that
					72% of positively selected human genes did not show a Ka/Ks &gt;
					1 (82% in chimp). Similarly, 314 (93%) human and 351
					(80%) chimp genes showing Ka/Ks &gt; 1 have not shown evidences
					of PS (black asterisks). Notice that most of these genes have evolved without
					signs of nonsynonymous deviations from clock behaviour, suggesting that these
					values of Ka/Ks &gt; 1 correspond to variations falling under a neutral
					model of evolution. The fact that many genes showed evidence of PS under
					clock-like behaviour (red and blue circles below the broken line) points out the
					high sensibility of the branch-site test employed where a few amino acid sites
					are probably involved in events of PS, without major changes in evolutionary
					rates between lineages (dKa).</p><p>In a similar manner, when considering differences in Ka rate instead of Ka/Ks
					rate ratios, 386 human genes (552 in chimp) have experienced a significant
					acceleration of nonsynonymous rate, and only approximately 32 of these genes
					(120 in chimp) have shown a reliable signal of PS. However, when considering
					genes with a significant acceleration in Ka rate and a dKa &gt; 0.0006, most
					of them show evidence of PS (81% in human and 94% in
					chimp). Although it is important to remember that they are still a minority out
					of all of the genes with a significant deviation in Ka-RRT.</p><p>In summary, we observe that only those genes with a significant Ka-RRT and dKa
					&gt; 0.0006 could possibly be considered as candidates for an enriched
					probability of having been positively selected. These results serve to highlight
					one of the downfalls of using elevated normalized Ka rates as a means of
					concentrating likely cases of PS in an a priori fashion.</p></sec><sec id="s2d"><title>Ancestral and Derived Trends of RSC and PS</title><p>It is known that most tests of PS are not able to distinguish real events of
					positive Darwinian selection from cases of RSC [<xref ref-type="bibr" rid="pcbi-0020038-b013">13</xref>]. This is the case with Test I
					used in this study. As has been previously demonstrated by Zang et al.
						[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>],
					the genes observed exclusively in Test I but not in Test II correspond to likely
					cases of RSC.</p><p><xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>A shows the
					distribution of total and common genes observed in both tests for the three
					lineages analyzed. As expected, the great majority of H-PSG and Ch-PSG shown in
					Test II were also observed in Test I. After correcting for multiple testing,
					216, 793, and 941 genes were detected in Test I for human, for chimp, and for
					the ancestral lineage, respectively. Only 122 human (1.26%), 245
					chimp (2.53%), and 287 ancestral (2.97%) genes were found
					exclusively in Test I. This exclusive set of genes was used to study the
					functional classes associated to likely cases of RSC.</p><fig id="pcbi-0020038-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.g002</object-id><label>Figure 2</label><caption><title>Phylogenetic Distribution of PSG under Tests I and II</title><p>(A) The differential distribution of genes along tree branches, suggests
							a different pattern of occurrence of PS (Test II) and RSC (Test I) in
							derived and ancestral lineages. Numbers in red represent the total
							number of genes detected in each test after correcting for multiple
							testing. Numbers in black are common orthologous genes observed between
							lineages. Numbers in blue are genes observed in both tests.</p><p>(B) The phylogenetic distribution of four representative GO categories is
							shown in human, in chimp, and in the ancestral lineage as depicted in
							the tree defined above. Numbers correspond to the percentage
							representation of genes under PS and RSC for each term out of the total
							number of genes with GO annotation. Filled circles show significant
							(red) and nonsignificant (grey) differences in the comparisons (see text
							for a detailed explanation).</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.g002" xlink:type="simple"/></fig><p><xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B shows the results
					of the statistical comparisons performed (filled circles) between the
					representations of genes (numbers on branches) observed under PS and RSC between
					human, chimp, and the ancestral lineage for four functional GO categories. These
					categories were among those most represented within both tests, and serve at the
					same time as examples of the different patterns of differentiation observed
					between common categories of human and of chimp.</p><p>A common pattern observed for all of the functional categories represented in the
					set of genes under RSC was the absence of functional differentiation between
					human and chimp (grey-filled circles). However, a highly significant increase
					(red-filled circles) occurred in the representation of the term
						<italic>G-protein coupled receptor protein signalling pathway</italic> in
					the derived lineages in comparison with the ancestral lineage (<xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B). This significant
					over-representation of genes under RSC was higher for human
					(+32.68%, <italic>p</italic> &lt; 1e-05) than for chimp
					(+18.36%, <italic>p</italic> = 0.006).
					Considering the time elapsed in each of the branches (approximately 75 Ma in the
					ancestral lineage against 5 Ma in the evolution of hominids), this suggests that
					a higher number of genes per unit time have experienced RSC after speciation in
					both this category and that of <italic>sensory perception</italic> (<xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B). Given that the
					relative representations of PSG belonging to <italic>G-protein coupled
					receptor</italic> and <italic>sensory perception</italic> increased in humans
					while decreasing in chimp after speciation (<xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref>, <xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B), it is not surprising that
					statistically significant differences were only detected in chimp (red-filled
					circles). Furthermore, <italic>G-protein coupled receptor</italic> and
						<italic>sensory perception</italic> were statistically over-represented
						(<italic>p</italic> &lt; 1e-05) when comparing the set of genes under
					RSC against the rest of the genes available in our dataset as representatives of
					the human genome. In summary, although both categories have increased in
					representation in human after speciation, a more frequent process of RSC has
					occurred under both of these, in both species.</p><p>The opposite pattern was observed for the <italic>cellular protein
					metabolism</italic> category (<xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B). In this case, the representation of genes under RSC
					decreased after speciation in both species. However, a higher representation of
					PSG under this category occurs in chimp and is the consequence of a marginal
					increase relative to the ancestral condition. A more pronounced reduction in the
					number of genes found under RSC occurred for the <italic>immune
					response</italic> category. In this case, no genes were observed to be under RSC
					in human, and considering the relative representation in each lineage, it seems
					to suggest that human showed little variation and chimp decreased in comparison
					to the ancestral proportion of PSG, while both species decreased under RSC.</p><p><xref ref-type="fig" rid="pcbi-0020038-g003">Figure 3</xref> shows the
					evolutionary changes in representations before and after the speciation process
					for all of the common GO classes deduced under both tests. The difference in
					representation between human and the ancestral lineage for each functional term
					(H-AH) is plotted against the difference observed between chimp and the
					ancestral lineage (CH-AH). Each point represents a functional category, and
					depending on its location in each one of the quadrants (Q) under both graphs,
					alternative evolutionary scenarios can be deduced. The diagonal represents a
					homogeneous increase (positive values) or decrease (negative values) in relation
					to values observed for the ancestral lineage during the evolution of both
					species.</p><fig id="pcbi-0020038-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.g003</object-id><label>Figure 3</label><caption><title>Ancestral and Derived Trends in Adaptation and RSC</title><p>Differences in GO term representation between the sets of the derived and
							the ancestral lineages (H-AH, human versus ancestral lineage; CH-AH,
							chimp versus ancestral lineage) are plotted against each other using
							genes exclusively observed in Test I (RSC) and Test II (PS). Each
							quadrant represents a particular evolutionary scenario increasing or
							decreasing in GO representation for each of the lineages after
							speciation. Terms showing a difference in representation between H-AH
							and CH-AH &gt;10% were labeled in red: <italic>G-coupled
								protein receptor</italic> was found in both Test I
							(14.32%) and Test II (12.89%), and <italic>sensory
								perception</italic> (11.03%) and <italic>cellular protein
								metabolism</italic> (−12.34%) in Test II. Only
							the terms common to all lineages are shown.</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.g003" xlink:type="simple"/></fig><p>GO terms with positive differences in representation in both axes correspond to
					those increasing in both species after the speciation process (Q1). Considering
					the adaptive evolutionary process, a total of 26 functional categories fits this
					pattern (PS graph). Most of them (21) showed higher differences in
					representation in human than in chimp (H-AH%, Ch-AH%),
					i.e., <italic>synaptic transmission</italic> (1.57, 0.68), <italic>detection of
						abiotic stimulus</italic> (2.87, 0.21), <italic>intracellular protein
						transport</italic> (5.73, 1.64), <italic>energy derivation by oxidation of
						organic components</italic> (3.13, 0.16), and <italic>small GTPase mediated
						signal transduction</italic> (2.87, 1.14), among others. Another 20 GO terms
					showed a relative increase in their relative representation in human while
					decreasing in chimp after speciation (Q4), i.e., <italic>G-protein coupled
						receptor</italic> and <italic>sensory perception</italic> (differences in
						<xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> and <xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B), <italic>electron
						transport</italic> (1.3, −2.65), <italic>male gamete
					generation</italic> (0.26, −1.57), <italic>blood vessel
					morphogenesis</italic> (1.04, −0.77) and <italic>wound
					healing</italic> (1.56, −0.23), among others. The opposite process,
					favoring the relative increase of PSG in chimp while decreasing in human, was
					detected for seven GO terms (Q3): <italic>apoptosis</italic> (−2.61,
					0.07), <italic>transcription</italic> (−4.42, 0.08),
						<italic>regulation of transcription</italic> (−2.68, 0.45), and
						<italic>cellular protein metabolism</italic> (differences in <xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> and <xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B), among others.
					Finally, a relative decrease from the ancestral representation of PSG was
					observed in six GO categories for both species (Q3): <italic>inflammatory
						response</italic> (−0.78, −2.61), <italic>response to
						pest, pathogens, and parasites</italic> (−1.82, −4.05),
					and <italic>immune response</italic> (differences in <xref ref-type="table" rid="pcbi-0020038-t004">Table 4</xref> and <xref ref-type="fig" rid="pcbi-0020038-g002">Figure 2</xref>B), among others.</p><p>In summary, although Test II detected a higher number of PSG in chimp than in
					human, and GO term representations between them were not significant, the
					comparison between ancestral and derived adaptive trends show that out of a
					total of 59 common GO terms to all lineages, 41 showed a higher proportion of PS
					events occurring in the human lineage. Only 11 terms showed a higher proportion
					of PSG in chimp. Additionally, the difference in data distributions between the
					sets of RSC/weak signal of PS and that of PS, suggested by <xref ref-type="fig" rid="pcbi-0020038-g003">Figure 3</xref>, is persuasive. While differences in
					the percentage of GO terms are widely distributed between the species,
					variations in GO representation of genes under RSC are highly correlated between
					variables (<italic>p</italic> = 3.6e-15) and fall mostly along the
					diagonal. The pattern describes a regular increase and decrease of genes
					undergoing RSC under each GO category at proportional and similar rates in both
					species after the speciation process. Only two of the GO terms deviated from
					this general pattern; <italic>G-protein coupled receptor</italic> and
						<italic>sensory perception</italic> were both located in Q1 below the
					diagonal, and serve to highlight the high proportion of genes under these
					categories that are likely cases of RSC in both species.</p><p>It is worth noting that the fact that many of the genes found exclusively in Test
					I have functionally important products, such as homeobox- and polymerase-related
					proteins among others, seems to suggest that it is highly improbable that all of
					them have undergone a process of RSC. Probably many of them are genes with a
					weak yet true signal of PS not sufficient to be detected by Test II (R. Nielsen,
					personal communication). It is evident that further statistical methods are
					necessary to accurately differentiate weak signals of PS from real cases of
				RSC.</p></sec><sec id="s2e"><title>Functional Roles of PSG in Human and in Chimp</title><p><xref ref-type="table" rid="pcbi-0020038-t005">Table 5</xref> shows the gene name
					of some of the PSG belonging to a select few of the more representative GO
					categories observed in the analyses. In agreement with the estimations based on
					an acceleration-rate approach [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>], many of the selection events
					associated to sensory perception in human and in chimp were detected in
					different genes related to auditory perception. For instance,
					<italic>EDN3</italic> was positively selected in human and is related to
					sensorineural deafness and hypopigmentation [<xref ref-type="bibr" rid="pcbi-0020038-b020">20</xref>]. <italic>USH1</italic> was
					positively selected in chimp, and its loss of function produces the most severe
					form of the Usher's syndrome [<xref ref-type="bibr" rid="pcbi-0020038-b021">21</xref>]. However, PS on genes related to
					the perception of sound was also found in the ancestral lineage. For instance,
					the <italic>KPTN</italic> murine ortholog is a candidate gene for the Nijmegan
					waltzer mouse mutant, which has vestibular defects and a variable sensorineural
					hearing loss [<xref ref-type="bibr" rid="pcbi-0020038-b022">22</xref>]. Other genes related to sensory perception were also found
					under PS: <italic>taste perception</italic> was principally observed in human
					and the ancestral lineage, <italic>visual perception</italic> and olfactory
					receptor genes were found in all of the lineages. Nevertheless, as was
					previously suggested [<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b013">13</xref>], most of the events of RSC found under the <italic>sensory
						perception</italic> category involved olfactory receptors. RSC in olfactory
					receptors was abundant in all three lineages. One striking observation was the
					high number of genes related to visual perception under RSC in the ancestral
					lineage of hominids. Although further research on this group of genes would be
					required, the observation probably makes sense considering the functional change
					produced by the loss of the nocturnal way of life in higher primates
						[<xref ref-type="bibr" rid="pcbi-0020038-b023">23</xref>].</p><table-wrap content-type="3col" id="pcbi-0020038-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.0020038.t005</object-id><label>Table 5</label><caption><p>A Small Sample of the Human and the Chimp Genes Deduced under Tests I and
							II</p></caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.t005" xlink:type="simple"/><!-- <table frame="hsides" rules="none"><colgroup><col id="tb5col1" align="left" charoff="0" char=""/><col id="tb5col2" align="left" charoff="0" char=""/><col id="tb5col3" align="left" charoff="0" char=""/><col id="tb5col4" align="left" charoff="0" char=""/><col id="tb5col5" align="left" charoff="0" char=""/><col id="tb5col6" align="left" charoff="0" char=""/><col id="tb5col7" align="left" charoff="0" char=""/></colgroup><thead><tr><td align="left" colspan="1" valign="top">GO Description</td><td colspan="3" valign="top"><hr/>Adaptive Evolution</td><td colspan="3" valign="top"><hr/>Relaxation of Selective Constraints/Weak Signal of PS</td></tr><tr><td></td><td>Human</td><td>Chimpanzee</td><td>Ancestral</td><td>Human</td><td>Chimpanzee</td><td>Ancestral</td></tr></thead><tbody><tr><td>Sensory perception</td><td><italic>EDN3 GRM6 HKR3</italic></td><td><italic>ABCA4 COL1A1 ERCC8</italic></td><td><italic>CCL1 CCL3 COL11A1</italic></td><td><italic>DFNB31 O2AG1 OR1072</italic></td><td><italic>CNGA2 GUCY2D O10D4</italic></td><td><italic>BBS2 CNGA1 COL1A2</italic></td></tr><tr><td></td><td><italic>OR2A14 OR51D1</italic></td><td><italic>GJA3 MYH9 MYO9A</italic></td><td><italic>CRB2 DSPP GPRC5D</italic></td><td><italic>OR10K1 OR10Q1 OR2B6</italic></td><td><italic>OR13G1 OR2A12 OR2B2</italic></td><td><italic>GUCY2D OPA3 OPN1SW</italic></td></tr><tr><td></td><td><italic>OR5D18 TS1R1</italic></td><td><italic>OR52N1OR5I1 ROBO1</italic></td><td><italic>IL8RA KPTN MYH14</italic></td><td><italic>OR3A3 OR4C16 OR51G1</italic></td><td><italic>OR2F2 OR2L2 OR4C13</italic></td><td><italic>OR11L1 OR2F2 OR4A16</italic></td></tr><tr><td></td><td></td><td><italic>USH1C</italic></td><td><italic>O10D4 OR10T2OR1B6</italic></td><td><italic>OR52E5 OR52N1 OR5J2</italic></td><td><italic>OR4FE OR4K13 OR51B4</italic></td><td><italic>OR4C16 OR4E2 OR51B4</italic></td></tr><tr><td></td><td></td><td></td><td><italic>OR5A1 OR5P3 PROM1 RP1</italic></td><td><italic>OR5T1 OR6K2 OR8J3</italic></td><td><italic>OR52E2 OR6P1 OR8I2</italic></td><td><italic>OR51I1 OR51V1 OR571</italic></td></tr><tr><td></td><td></td><td></td><td><italic>TAS1R3 TAS2R38 TAS2R41</italic></td><td></td><td><italic>OR9A4 PCDH15 TAS2R60</italic></td><td><italic>OR5AS1 OR8J1 OR8J3</italic></td></tr><tr><td></td><td></td><td></td><td><italic>TRPA1</italic></td><td></td><td><italic>TECTA</italic></td><td><italic>TNFRSF11A TRPM8</italic></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td><italic>TULP2</italic></td></tr><tr><td>G-PCR signalling pathway<sup>a</sup></td><td><italic>GPR111 HKR3 OR52W1</italic></td><td><italic>ADRA1B ADRA2A SORCS1</italic></td><td><italic>AAR5 ADRA1A AS1R3</italic></td><td><italic>CAP1 IMPG2 OR10T2</italic></td><td><italic>ADRA1D CALM1ECE2</italic></td><td><italic>OR4C15 OR4E2 OR5T2</italic></td></tr><tr><td></td><td><italic>PTGER4 TS1R1</italic></td><td><italic>GRPR AKAP12 TAAR1</italic></td><td><italic>CCL3 CCR2 CD3 EDRD2</italic></td><td><italic>OR3A3 Q8NG2 Q8NGU0</italic></td><td><italic>ELSR2 OR2B2 OR2T4</italic></td><td><italic>PYY TSHR</italic></td></tr><tr><td></td><td></td><td><italic>TAAR6 PARD3 HTR5A</italic></td><td><italic>ENPP2 GABBR1 GALR2</italic></td><td><italic>Q8NH71 Q8NH88 RBP3</italic></td><td><italic>OR4C11 OR52M1 OR6K6</italic></td><td></td></tr><tr><td></td><td></td><td><italic>EDG8 OR8D2</italic></td><td><italic>GAP43 GLP1R GPCR116</italic></td><td><italic>TSHR</italic></td><td><italic>PLCE1 R4C13 RAMP3</italic></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>GPR154 GPR43 HTR1D</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>IL8RA MRGPRD OR13A1</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>PLCE1 PTHR1 RAI3</italic></td><td></td><td></td><td></td></tr><tr><td>Immune response<sup>b</sup></td><td><italic>CCL4 ITGAL ITGB1</italic></td><td><italic>AFP AMBP CSF1R CSF2RB</italic></td><td><italic>AHSG ARTS1 AZGP1 CCL1</italic></td><td></td><td>CRIP1 ELF4 IVNS1ABP</td><td>CAMP CFH C1QG GSR</td></tr><tr><td></td><td></td><td><italic>GABBR1 HFE HLA-G HLA-J</italic></td><td><italic>CCL3 CCR2 CD72 CD80</italic></td><td></td><td>ODZ1 PARP4 STAB1</td><td>INHA PRF1 PTGS2</td></tr><tr><td></td><td></td><td><italic>IGSF2 IKBKE IL1F10 IL1R1</italic></td><td><italic>CRISP3 CSF3 D3E EXOSC9</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><italic>KLF6 OTUB1 SEMA7A</italic></td><td><italic>FCGR2B FCN2 FTH1 GBP1</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><italic>STAT5A TCF7 UBD</italic></td><td><italic>GBP2 HLA-DOB HLA-F</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>HLA-G HLA-H ICOS IL18</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>ITGAL LIRA4 LTB4R LY75</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>NFX1 S100A9 STAT3 TLR1</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td><italic>TREM1 TRIM22</italic></td><td></td><td></td><td></td></tr><tr><td>DNA/RNA<sup>c</sup></td><td><italic>CHTF18 NASP</italic></td><td><italic>ARID1A ERCC8 FANCG</italic></td><td><italic>ARSL CASKIN1 CIDEA</italic></td><td><italic>EPRS SUPT6H</italic></td><td><italic>ADRA1D CHD5 CHTF18</italic></td><td><italic>ADARB2 MCM3AP</italic></td></tr><tr><td></td><td></td><td><italic>LIG1 MSH4 MUS81 MYST3</italic></td><td><italic>DCP2DHX15 ELAVL4</italic></td><td></td><td><italic>DARS IVNS1ABP NAP1L5</italic></td><td><italic>MRE11A MSH2 POLQ</italic></td></tr><tr><td></td><td></td><td><italic>POLD3 POLI RAD23B RFC1</italic></td><td><italic>EXOSC9 HILS1 NEIL2</italic></td><td></td><td><italic>ORCL3 PAPR4 POLRMT</italic></td><td><italic>POLRMUT RPUSD4 SMN1</italic></td></tr><tr><td></td><td></td><td><italic>SUPT6H TOPBP1 TP73</italic></td><td><italic>NF1B NFIC NFX1 NOLC1</italic></td><td></td><td><italic>SHPRH SUPT5H</italic></td><td><italic>CYCS SUPT6H SYV</italic></td></tr><tr><td></td><td></td><td><italic>UBE1 UV39H2 XRCC4</italic></td><td><italic>OGG1 PARP2 POLE2 POLG</italic></td><td></td><td></td><td><italic>XRCC5</italic></td></tr><tr><td></td><td></td><td></td><td><italic>POLM POLN RAD51L3</italic></td><td></td><td></td><td></td></tr><tr><td>Transcription<sup>d</sup></td><td><italic>ARNT2 KLF14 NFKB2</italic></td><td><italic>ASCL1 CDC5L CEPPZ</italic></td><td><italic>ATF4 BGALP BLZF1 CD80</italic></td><td><italic>AGGF1 CREM FOXI1</italic></td><td><italic>CHD5 E2F1 ELF4 GMEB2</italic></td><td><italic>CEBPZ ETS2 PER2</italic></td></tr><tr><td></td><td></td><td><italic>COA5 EDF1 ERCC8 FLI1</italic></td><td><italic>CNOT4 DMRTC2 EGR4</italic></td><td><italic>GLIS3 GRIP1 LHX1 MYEF2</italic></td><td><italic>HNF4A HOXA1 HOXA3</italic></td><td><italic>PMFBP1 POLRMT SOX30</italic></td></tr><tr><td></td><td></td><td><italic>GLI1 HUWE1 KCNH5</italic></td><td><italic>ERG ETV2 MEF2B MXD4</italic></td><td><italic>POLR3K SUPT6H TITF1</italic></td><td><italic>KLF3 NOC3L PHF19</italic></td><td><italic>SP110 SUPT6H TERF2IP</italic></td></tr><tr><td></td><td></td><td><italic>KLF12 KLF6 MYEF2</italic></td><td><italic>NANOG NF1B NFIC NFX1</italic></td><td><italic>ZFP37 ZNF76</italic></td><td><italic>POLR1A POLRMT SALL2</italic></td><td><italic>TRIB3 TSC22D4 VCPIP1</italic></td></tr><tr><td></td><td></td><td><italic>MYST3 NPAS1 PHF15</italic></td><td><italic>PHF20 POLR1A POLR2J</italic></td><td></td><td><italic>SIX1 SSRP1 TEAD2 VGLL4</italic></td><td><italic>YBOX2 ZBTB3</italic></td></tr><tr><td></td><td></td><td><italic>PHF20 POLR1B POLR2A</italic></td><td><italic>RBM9 RELA SALF SHPRH</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><italic>POLR3B PRDM1 RFC1</italic></td><td><italic>SIN3A SOX15 STAT3 TBX6</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><italic>RRAGC SNAPC1 ST18</italic></td><td><italic>TF2AY TLE4 TRIM22</italic></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td><italic>STAT5A SUPT6H TCF7</italic></td><td><italic>TULP4 ZNF317</italic></td><td></td><td></td><td></td></tr><tr><td>Cellular protein metabolism</td><td><italic>BMP2K GZMB MAPK8</italic></td><td><italic>ACE ACR ADAM11 ATE1</italic></td><td><italic>A2M ALG1 APOE ARTS1</italic></td><td><italic>DAG1 EPHB6 EPRS GPA11</italic></td><td><italic>CHD5 COG2 DARS ECE2</italic></td><td><italic>ADAMTS1 BHMT CCRK</italic></td></tr><tr><td></td><td><italic>RRBP1 SRCUSP44</italic></td><td><italic>BIRC4 CAPN6 CASP6 CASP8</italic></td><td><italic>BMP2K CAMK2D</italic></td><td><italic>LAMC1 RANBP2 RNF40</italic></td><td><italic>GUCY2D HSF1 LPAMARK1</italic></td><td><italic>CTSW DK4 EEF1GF13A1</italic></td></tr><tr><td></td><td></td><td><italic>CDC2L5 CIT CUL1</italic></td><td><italic>CDC42BPB CIT CNOT4</italic></td><td><italic>RPL11 TMPRSS2 TRIM50C</italic></td><td><italic>MYLK2 PARP3 PARP4</italic></td><td><italic>FGG GALNT6 GRPEL2</italic></td></tr><tr><td></td><td></td><td><italic>DAG1 DNAJC11 EGFR FYN</italic></td><td><italic>COG8 CPB2 CTSB DAPK1</italic></td><td><italic>USP2 USP47 ZNF294</italic></td><td><italic>PTPRC RNF141 RPL31</italic></td><td><italic>KLK15 KLK19 LGMN</italic></td></tr><tr><td></td><td></td><td><italic>HECW1 HFE HSPCB HUWE1</italic></td><td><italic>DMPK ELA2A ERG ERO1L</italic></td><td></td><td><italic>RPS27 SCPEP1 SHH TIPARP</italic></td><td><italic>LMLN LRP2 MMP2</italic></td></tr><tr><td></td><td></td><td><italic>MAP2 MKNK1 MNAB</italic></td><td><italic>HARSL HPT HTRA2 LRP8</italic></td><td></td><td><italic>TPSD1 TRIM8 TSTA3</italic></td><td><italic>MRE11A MRPL3 MRPS30</italic></td></tr><tr><td></td><td></td><td><italic>MTMR1 MYPEP MYST3</italic></td><td><italic>NEDD4 NEK11 PARP2 PEN2</italic></td><td></td><td></td><td><italic>OPN1SW PAPPA RNF8</italic></td></tr><tr><td></td><td></td><td><italic>NEO1 NEURL NLN PRSS3</italic></td><td><italic>PIGQ REN RIPK3 SLMAP</italic></td><td></td><td></td><td><italic>SLC7A11 SMN1 SPTA1</italic></td></tr><tr><td></td><td></td><td><italic>PSMB5 RAD23B SRPK1</italic></td><td><italic>STK16 STK3 TGM1 TLR1</italic></td><td></td><td></td><td><italic>TBB6 TGFBR2 TRIB 3</italic></td></tr><tr><td></td><td></td><td><italic>TFRC TOR1A USP40 USP48</italic></td><td><italic>USP49 VPS11</italic></td><td></td><td></td><td><italic>TRIM37 TRPM6 TSSK1</italic></td></tr></tbody></table> --><!-- <table-wrap-foot><fn id="nt501"><p>Genes deduced under specific lineages and evolutionary processes.</p></fn><fn id="nt502"><p><sup>a</sup>G-protein coupled receptor protein signalling pathway.</p></fn><fn id="nt503"><p><sup>b</sup>Immune response includes humoral immune response and response to pest pathogens and parasites.</p></fn><fn id="nt504"><p><sup>c</sup>DNA/RNA includes <italic>RNA</italic> and <italic>DNA metabolism, DNA repair,</italic> and <italic>regulation of DNA metabolism</italic>.</p></fn><fn id="nt505"><p><sup>d</sup>Transcription includes its regulation.</p></fn></table-wrap-foot> --></table-wrap><p>Many other genes with a strong signal of PS in human (H), in chimp (Ch), in human
					and chimp (H-Ch), and in the ancestral lineage of hominids (AH) were related to:
					a) nervous system, H: <italic>ARNT2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b024">24</xref>], H: <italic>GFRalpha</italic>-3
						[<xref ref-type="bibr" rid="pcbi-0020038-b025">25</xref>],
					Ch: <italic>DRP2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b026">26</xref>], <italic>NES</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b027">27</xref>];
					b) immune response, H: <italic>PTGER4</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b028">28</xref>], <italic>CCL4</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b029">29</xref>],
					Ch: <italic>AFP</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b030">30</xref>], <italic>HLA-G</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b031">31</xref>], H-Ch: <italic>IGHG3</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b032">32</xref>],
					AH: <italic>HLA-DOB</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b033">33</xref>]; c) cell cycle, H:
					<italic>VEGFC</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b034">34</xref>], Ch: <italic>CCNE2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b035">35</xref>], AH:
						<italic>EXT2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b036">36</xref>], <italic>SEPTIN8</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b037">37</xref>];
					d) metabolism of xenobiotics, H: <italic>ARNT2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b038">38</xref>]; Ch:
						<italic>AKR1C1</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b039">39</xref>], AH: <italic>ABCB4</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b040">40</xref>];
					e) epidermis development, H: <italic>KRA58</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b041">41</xref>], Ch:
						<italic>KRT10</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b042">42</xref>], <italic>COL7A1</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b043">43</xref>],
					AH: <italic>TGM5</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b044">44</xref>], <italic>KTR2A</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b045">45</xref>];
					f) inflammatory response, H: <italic>ITGAL</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b046">46</xref>],
					<italic>CCL4</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b029">29</xref>], Ch: <italic>IL1F10</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b047">47</xref>],
					<italic>IL1R1</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b048">48</xref>], AH: <italic>CCL3, CCL1, CCR2</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b049">49</xref>]; g) bone
					morphogenesis, H-CH-AH: BMP2K [<xref ref-type="bibr" rid="pcbi-0020038-b050">50</xref>], Ch: <italic>COL1A1</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b051">51</xref>],
						<italic>DCN</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b052">52</xref>], AH: <italic>BGLAP</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b053">53</xref>],
					<italic>AHSG</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b054">54</xref>]; h) learning and memory, Ch: <italic>FYN</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b055">55</xref>],
						<italic>GRIN2A</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b056">56</xref>], AH: <italic>APOE</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b057">57</xref>]
					i) thyroid regulation, Ch: <italic>SLC5A5</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b058">58</xref>],
					<italic>JMJD1C</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b059">59</xref>]; AH: <italic>CGA</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b060">60</xref>],
					<italic>PTHR1</italic> [<xref ref-type="bibr" rid="pcbi-0020038-b061">61</xref>]; and j) reproduction, Ch: <italic>CGA</italic>
						[<xref ref-type="bibr" rid="pcbi-0020038-b062">62</xref>].</p><p>These functions are a small sample of those observed in this study and point out
					the great variety of functions modified by natural selection during hominid
					evolution.</p></sec></sec><sec id="s3"><title>Discussion</title><p>We present a complete genomic evolutionary analysis of molecular clock, RSC, and PS
				considering the comparison with the ancestral lineage of hominids in order to
				differentiate adaptive trends in evolution after the speciation process
				differentiating human and chimpanzee. Based on testing deviations of neutrality in a
				gene-by-gene approach, we found a total of 1,182 (9.0%) human and 1,948
				(14.8%) chimp genes with statistically significant deviations observed in
				at least one of the mentioned processes. However, after correcting for multiple
				testing we only considered 665 (5.0%) human and 1,341 (10.2%)
				chimp genes as a better estimate of the minimal sets under non-neutral evolution in
				these species. We conclude that these evolutionary processes do not show signs of
				being frequent events shaping the pattern of divergence between human and chimp
				genomes.</p><p>Differences in evolutionary rates exist between the species although there were no
				net significant differences. The number of genes showing a significant acceleration
				in non-synonymous rates exceeds those evolving by synonymous changes, and is greater
				for chimp than for humans. This excess of nonsynonymous changes favoring chimp
				correlates with the greater number of PS events observed in this species, and could
				be due in part to the comparatively smaller population size that has shaped human
				evolution [<xref ref-type="bibr" rid="pcbi-0020038-b063">63</xref>].</p><p>For years, evolutionary biologists have known that deviations from the molecular
				clock, or rate acceleration in general, are not necessary, nor sufficient, to infer
				adaptive processes occurring during evolution of species. We have observed that a
				consideration of genes with a Ka/Ks &gt; 1 yield a set where only
				7%–20 % of genes show evidences of PS. Similarly,
				using a RRT approach on nonsynonymous mutations, those showing significant
				deviations are enriched for PS events from 10%–30%.
				With the addition of a nontrivial divergence value (dKa &gt; 0.0006), the number
				of genes is reduced considerably, but PS events reach a concentration of
				80%–95%. However, in all of these cases a high
				proportion of PSG are discarded in comparison with the number of PS events found by
				using the ML branch-site models of Test II used in this study.</p><p>A previous genomic study focusing on PS selection in human and in chimp has found
				that many functional categories were over- and under-represented in both species
					[<xref ref-type="bibr" rid="pcbi-0020038-b010">10</xref>].
				This was in disagreement with the results obtained in a posterior study
					[<xref ref-type="bibr" rid="pcbi-0020038-b012">12</xref>]
				where only one GO category (developmental regulators) showed a possible
				over-representation in human in relation to chimp. In this publication, the
				possibility that the results of Clark et al. [<xref ref-type="bibr" rid="pcbi-0020038-b010">10</xref>] were either likely to contain false
				positives involved in RSC or had RSC and PS correlated, was proposed. Our results
				tend to agree more with this last study, providing evidence for the lack of
				differentiation in functional classes of PSG in human and in chimp. Our results also
				support the notion that Clark's results may have included cases of RSC given that
				the model 2 test used in that study is very similar to Test I used here and that
				many of the deduced classes are here observed with a marked presence under RSC
					<italic>(G-protein coupled receptor</italic> and <italic>sensory
				perception)</italic>. However, a probable correlation between PS and RSC could not
				be discarded since highly represented functional classes under one of the processes
				are also highly represented in the other.</p><p>The sets of genes deduced without correction for multiple testing in molecular clock
				and PS analyses produced similar results for most of the GO representation
				comparisons observed after correction. The only exception was the term
					<italic>G-protein coupled receptor protein signalling pathway</italic> found to
				be additionally over-represented in human in relation to chimp under PS (Test II,
					<italic>p</italic> = 0.005). As previously mentioned, after
				correction for multiple testing we have not found GO terms over- or
				under-represented between both species. However, if differences between human and
				chimp are considered as independent trends evolving from the ancestral condition, a
				certain pattern seems apparent—although ancestral and descendent
				differences were not statistically significant. That is, we observe that a relative
				increase of PSG occurred in human for 41 out of the 59 GO categories common to all
				of the lineages, while only 11 showed a relative increase in chimp even though PSG
				in human are six times less than those in chimp. Although further studies would be
				required, this might suggest that in at least common fuctional GO classes, human has
				grown further apart from the ancestral lineage than chimp has through adaptive
				evolution. Finally, since most of the PSG are different between these species, the
				individual roles of the alternative PSG found associated under the same functional
				categories may be an important factor underlying biological differences between
				human and chimp.</p><p>Whole-genome analyses of evolutionary properties were made without any a priori
				hypothesis about the resulting genes. Consequently, these types of analyses are
				exhaustive and, at the same time, conservative regarding individual results. The
				necessity of keeping the type I error rate at an acceptable level leads to an
				unavoidable increase in the rejection of true positive results [<xref ref-type="bibr" rid="pcbi-0020038-b064">64</xref>]. Therefore, the
				complete sets of accelerated and PSG we have found can only be considered their
				respectively most significant parts. The rest of the genes belonging to these
				categories must be found either by using hypothesis-driven approaches, or by means
				of more sensitive methodologies. In this study, previously discussed examples of PS,
				such as <italic>FOXP2</italic> and <italic>BRCA1,</italic> did not show evidence of
				PS. This would suggest that further detailed work on these genes is required.</p><p>For years it has been thought that the availability of the chimpanzee genome sequence
				and its comparison to that of human would reveal some of the molecular bases
				underlying the observable differences and possibly provide clues to that which makes
				us human. Now it is evident that neither the methodologies existing nor the detail
				and quality of the available annotation on the genes have allowed for a conclusive
				answer. In the future, new methods and more detailed functional annotations will be
				necessary to properly clarify this relevant biological issue.</p></sec><sec id="s4"><title>Materials and Methods</title><p>Ortholog annotations for the subset of 20,469 “known” Ensembl
				human protein-coding genes within the full set (30,709 genes) of the Ensembl version
				30.35h <named-content content-type="genus-species" xlink:type="simple">H. sapiens</named-content>
				database [<xref ref-type="bibr" rid="pcbi-0020038-b065">65</xref>]
				were retrieved from the Ensembl-Compara database version 30 [<xref ref-type="bibr" rid="pcbi-0020038-b066">66</xref>]. Coding sequences
				(CDS) for the proteins represented by the largest transcript of each ortholog were
				retrieved from the Ensembl databases (Human: version 30.35c, Chimp: version 30.2,
				Mouse: version 30.33f, Rat: version 30.34, Dog: version 30.1b).</p><p>DNA CDS were aligned using ClustalW [<xref ref-type="bibr" rid="pcbi-0020038-b067">67</xref>] and parameters by default with
				translated protein sequences as templates. Codons containing gaps were removed.
				Alignments smaller than 50 bp were excluded from the analysis. The upper limit for
				Ka and Ks rates considered were those of the human <underline>interferon
						<italic>γ</italic></underline> (Ka = 3.06) and the
					<underline>relaxin</underline> protein (Ks = 6.39 substitutions per
				site per 10<sup>9</sup> years), showing the highest rates in human [<xref ref-type="bibr" rid="pcbi-0020038-b005">5</xref>]. Assuming the
				human–mouse and human–chimp differentiation times to be about 80
				million and 5 million years, respectively [<xref ref-type="bibr" rid="pcbi-0020038-b068">68</xref>], all the comparisons with orthologs
				showing Ks ≥ 1 and Ka ≥ 0.5 substitutions/site for the RRT estimates,
				and those showing Ks ≥ 0.032 and Ka ≥ 0.0152 substitutions/site for ML
				lineage estimates, were excluded from the analysis. The RRT was performed using Li's
				method [<xref ref-type="bibr" rid="pcbi-0020038-b069">69</xref>]
				as implemented in the RRTree program [<xref ref-type="bibr" rid="pcbi-0020038-b070">70</xref>]. Sequences of human and of chimp
				were tested for deviation from a molecular clock using mouse, rat, and dog as the
				outgroup. Weights for each species in the outgroup were determined according to the
				topological scheme ((mouse:1/4, rat:1/4), dog:1/2)) as implemented in RRTree. Ka and
				Ks estimations were made on the CDS alignments of the largest transcripts of genes
				showing differences in GC content of less than 10%. Only three genes
				showed a GC content difference greater than 10% and were excluded from
				the analysis. Differences in human and in chimp rates were assessed using the
				Kolmogorov–Smirnov two-sample test [<xref ref-type="bibr" rid="pcbi-0020038-b071">71</xref>]. ML estimations of Ka and Ks were
				computed jointly under a branch model for each ortholog using CodeML.</p><p>PS was evaluated using two different branch-site model Tests (I and II)
					[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>],
				implemented in the CodeML program of the PAML (3.15) package [<xref ref-type="bibr" rid="pcbi-0020038-b016">16</xref>]. Branches in the
				phylogeny were defined a priori as foreground and background lineages. Under these
				models only the foreground lineage may contain events of PS. Human, chimp, and their
				ancestral lineage, derived from the common ancestor of mouse and rat, were tested
				independently as the foreground lineage. Sequences with fewer than three unique base
				pair differences in codons between human and chimp were removed for the analysis of
				PS.</p><p>In contrast to the statistical behavior of previous branch-site tests [<xref ref-type="bibr" rid="pcbi-0020038-b013">13</xref>], Tests I and II,
				developed and tested by Zhang et al. [<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>] and employed at a genomic scale in
				this study, are improved methods of branch-site test models using an ML approach
				which has proved to be more successful with regard to differentiating PS from RSC
					[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>].
				Test I compares M1a against model A. M1a assumes two site classes, 0 &lt;
					ω<sub>o</sub> &lt; 1 and ω<sub>1</sub> = 1,
				fixed in all the lineages of the phylogenetic tree. Model A considers four classes
				of sites. Site class 0 includes codons conserved throughout the tree with 0 &lt;
					ω<sub>o</sub> &lt; 1. Site class 1 includes codons evolving
				neutrally throughout the tree with ω<sub>1</sub> = 1. Site
				classes 2a and 2b include codons conserved or evolving neutrally on the background
				branches, but which become under PS on the foreground branches with
					ω<sub>2</sub> &gt; 1. The proportion p<sub>i</sub> of the site
				classes (p<sub>0</sub>,p<sub>1</sub>,p<sub>2</sub>,p<sub>3</sub>) and the mean value
				of ω<sub>2</sub> are estimated from the data by ML methods. Test II
				compares the null model A1 against model A. Parameters in A1 are equal to those of A
				with the exception that site classes 2a and 2b are fixed in the foreground with
					ω<sub>2</sub> = 1. As was demonstrated by simulations
					[<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>],
				Test I cannot suitably distinguish cases of RSC from true events of PS. On the other
				hand, Test II, by allowing selectively constrained sites in the background to become
				relaxed under the proportion of site classes with ω<sub>2</sub>
				= 1 set in the foreground of A1, is able to make this distinction, having
				an acceptable false discovery rate. One can therefore compare the results of both
				tests to distinguish cases of PS from events of RSC. Since the compared models are
				nested, likelihood ratio tests were performed and 2Δ values were
				posteriorly transformed into exact <italic>p-</italic>values using the pchisq
				function of the R statistical package [<xref ref-type="bibr" rid="pcbi-0020038-b072">72</xref>]. The chi-squared distribution with
				d.f. = 2 and d.f. = 1, which have been shown to be
				conservative under conditions of PS [<xref ref-type="bibr" rid="pcbi-0020038-b014">14</xref>], were used to perform Tests I and
				II, respectively.</p><p>In all cases, unless otherwise stated, p statistics derived from clock and PS
				analysis were false discovery rate–adjusted for multiple testing using the
				method of Benjamini and Hochberg [<xref ref-type="bibr" rid="pcbi-0020038-b073">73</xref>]. Functional characterization of
				accelerated and PSG was carried out by means of the FatiGO program for functional
				annotation using GO [<xref ref-type="bibr" rid="pcbi-0020038-b018">18</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b019">19</xref>].
				FatiGO implements an inclusive analysis, where levels correspond to those in the
				directed acyclic graphs hierarchy defining the relationship between GO terms
					[<xref ref-type="bibr" rid="pcbi-0020038-b074">74</xref>]
				which is chosen for the analysis [<xref ref-type="bibr" rid="pcbi-0020038-b018">18</xref>,<xref ref-type="bibr" rid="pcbi-0020038-b019">19</xref>]. The program computes a Fisher's two-tail exact test in
				order to statistically define over- or under-represented terms in between two lists
				of genes considering <italic>p</italic>-values corrected for multiple testing (false
				discovery rate–independent adjustment) [<xref ref-type="bibr" rid="pcbi-0020038-b075">75</xref>].</p></sec><sec id="s5"><title>Supporting Information</title><supplementary-material id="pcbi-0020038-sd001" mimetype="text/plain" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.sd001" xlink:type="simple"><label>Dataset S1</label><caption><title>GO Functional Analysis Results of RRT and PS Tests</title><p>(173 KB ZIP)</p></caption></supplementary-material><supplementary-material id="pcbi-0020038-st001" mimetype="text/plain" position="float" xlink:href="info:doi/10.1371/journal.pcbi.0020038.st001" xlink:type="simple"><label>Table S1</label><caption><title>Variables Obtained for All the Orthologous Genes</title><p>(1.8 MB ZIP)</p></caption></supplementary-material></sec></body><back><ack><p>We thank Rasmus Nielsen for providing unpublished results on the statistical behavior
				of Tests I and II and valuable comments on this paper.</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>AH-PSG</term><def><p>PSG in the ancestral hominid lineage</p></def></def-item><def-item><term>CDS</term><def><p>coding sequences</p></def></def-item><def-item><term>ChF</term><def><p>chimp faster than human</p></def></def-item><def-item><term>Ch-PSG</term><def><p>chimp PSG</p></def></def-item><def-item><term>CSAC</term><def><p>Chimpanzee Sequencing and Analysis Consortium</p></def></def-item><def-item><term>GO</term><def><p>gene ontology</p></def></def-item><def-item><term>HF</term><def><p>human faster than chimp</p></def></def-item><def-item><term>H-PSG</term><def><p>human PSG</p></def></def-item><def-item><term>Ka</term><def><p>nonsynonymous rate of evolution in substitutions per site</p></def></def-item><def-item><term>Ka-RRT</term><def><p>relative rates test on nonsynonymous sites</p></def></def-item><def-item><term>K–S</term><def><p>Kolmogorov–Smirnov</p></def></def-item><def-item><term>Ks</term><def><p>synonymous rate of evolution in substitutions per site</p></def></def-item><def-item><term>ML</term><def><p>maximum-likelihood</p></def></def-item><def-item><term>PS</term><def><p>positive selection</p></def></def-item><def-item><term>PSG</term><def><p>positively selected genes</p></def></def-item><def-item><term>Q</term><def><p>quadrant</p></def></def-item><def-item><term>RRT</term><def><p>relative rates test</p></def></def-item><def-item><term>RSC</term><def><p>relaxation of selective constraints</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pcbi-0020038-b001"><label>1</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Gillespie</surname><given-names>JH</given-names></name></person-group>
					<year>1991</year>
					<source>The causes of molecular evolution</source>
					<publisher-loc>Oxford</publisher-loc>
					<publisher-name>Oxford University Press</publisher-name>
					<!--===== Restructure page-count as size[@units="page"] =====--><size units="page">336</size>
					<comment>p.</comment>
				</element-citation></ref><ref id="pcbi-0020038-b002"><label>2</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name></person-group>
					<year>1968</year>
					<article-title>Evolutionary rate at the molecular level.</article-title>
					<source>Nature</source>
					<volume>217</volume>
					<fpage>624</fpage>
					<lpage>626</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b003"><label>3</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kimura</surname><given-names>M</given-names></name></person-group>
					<year>1983</year>
					<source>The neutral theory of molecular evolution</source>
					<publisher-loc>Cambridge/London</publisher-loc>
					<publisher-name>Cambridge University Press</publisher-name>
					<!--===== Restructure page-count as size[@units="page"] =====--><size units="page">367</size>
					<comment>p.</comment>
				</element-citation></ref><ref id="pcbi-0020038-b004"><label>4</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>JL</given-names></name><name name-style="western"><surname>Jukes</surname><given-names>TH</given-names></name></person-group>
					<year>1969</year>
					<article-title>Non-Darwinian evolution.</article-title>
					<source>Science</source>
					<volume>164</volume>
					<fpage>788</fpage>
					<lpage>798</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b005"><label>5</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WS</given-names></name></person-group>
					<year>1997</year>
					<source>Molecular evolution</source>
					<publisher-loc>Sunderland (Massachusetts)</publisher-loc>
					<publisher-name>Sinauer Associates</publisher-name>
				</element-citation></ref><ref id="pcbi-0020038-b006"><label>6</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name></person-group>
					<year>2001</year>
					<article-title>Statistical tests of selective neutrality in the age of genomics.</article-title>
					<source>Heredity</source>
					<volume>86</volume>
					<fpage>641</fpage>
					<lpage>647</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b007"><label>7</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Bromham</surname><given-names>L</given-names></name><name name-style="western"><surname>Penny</surname><given-names>D</given-names></name></person-group>
					<year>2003</year>
					<article-title>The modern molecular clock.</article-title>
					<source>Nat Rev Genet</source>
					<volume>4</volume>
					<fpage>216</fpage>
					<lpage>224</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b008"><label>8</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zuckerkandl</surname><given-names>E</given-names></name><name name-style="western"><surname>Pauling</surname><given-names>L</given-names></name></person-group>
					<year>1965</year>
					<article-title>Molecules as documents of evolutionary history.</article-title>
					<source>J Theor Biol</source>
					<volume>8</volume>
					<fpage>357</fpage>
					<lpage>366</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b009"><label>9</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Dorus</surname><given-names>S</given-names></name><name name-style="western"><surname>Vallender</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Evans</surname><given-names>PD</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>SL</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Accelerated evolution of nervous system genes in the origin of
						Homo sapiens.</article-title>
					<source>Cell</source>
					<volume>119</volume>
					<fpage>1027</fpage>
					<lpage>1040</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b010"><label>10</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>AG</given-names></name><name name-style="western"><surname>Glanowski</surname><given-names>S</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>PD</given-names></name><name name-style="western"><surname>Kejariwal</surname><given-names>A</given-names></name><etal/></person-group>
					<year>2003</year>
					<article-title>Inferring nonneutral evolution from
						human–chimp–mouse orthologous gene trios.</article-title>
					<source>Science</source>
					<volume>302</volume>
					<fpage>1960</fpage>
					<lpage>1963</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b011"><label>11</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>C</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AG</given-names></name><name name-style="western"><surname>Glanowski</surname><given-names>S</given-names></name><name name-style="western"><surname>Sackton</surname><given-names>TB</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>A scan for positively selected genes in the genomes of humans and
						chimpanzees.</article-title>
					<source>PLoS Biol</source>
					<volume>3</volume>
					<issue>(6)</issue>
					<elocation-id>e170.</elocation-id>
					<comment>DOI: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pbio.0030170" xlink:type="simple">10.1371/journal.pbio.0030170</ext-link></comment>
				</element-citation></ref><ref id="pcbi-0020038-b012"><label>12</label><element-citation publication-type="journal" xlink:type="simple">
					<collab xlink:type="simple">CSAC</collab>
					<year>2005</year>
					<article-title>Initial sequence of the chimpanzee genome and comparison with the
						human genome.</article-title>
					<source>Nature</source>
					<volume>437</volume>
					<fpage>69</fpage>
					<lpage>87</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b013"><label>13</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name></person-group>
					<year>2004</year>
					<article-title>Frequent false detection of positive selection by the likelihood
						method with branch-site models.</article-title>
					<source>Mol Biol Evol</source>
					<volume>21</volume>
					<fpage>1332</fpage>
					<lpage>1339</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b014"><label>14</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>R</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name></person-group>
					<year>2005</year>
					<article-title>Evaluation of an improved branch-site likelihood method for
						detecting positive selection at the molecular level.</article-title>
					<source>Mol Biol Evol</source>
					<volume>22</volume>
					<fpage>2472</fpage>
					<lpage>2479</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b015"><label>15</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ohta</surname><given-names>T</given-names></name><name name-style="western"><surname>Ina</surname><given-names>Y</given-names></name></person-group>
					<year>1995</year>
					<article-title>Variation in synonymous substitution rates among mammalian genes
						and the correlation between synonymous and nonsynonymous divergences.</article-title>
					<source>J Mol Evol</source>
					<volume>41</volume>
					<fpage>717</fpage>
					<lpage>720</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b016"><label>16</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name></person-group>
					<year>1997</year>
					<article-title>PAML: A program package for phylogenetic analysis by maximum
						likelihood.</article-title>
					<source>Comput Appl Biosci</source>
					<volume>13</volume>
					<fpage>555</fpage>
					<lpage>556</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b017"><label>17</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ashburner</surname><given-names>M</given-names></name><name name-style="western"><surname>Ball</surname><given-names>CA</given-names></name><name name-style="western"><surname>Blake</surname><given-names>JA</given-names></name><name name-style="western"><surname>Botstein</surname><given-names>D</given-names></name><name name-style="western"><surname>Butler</surname><given-names>H</given-names></name><etal/></person-group>
					<year>2000</year>
					<article-title>Gene ontology: Tool for the unification of biology. The Gene
						Ontology Consortium.</article-title>
					<source>Nat Genet</source>
					<volume>25</volume>
					<fpage>25</fpage>
					<lpage>29</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b018"><label>18</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Al-Shahrour</surname><given-names>F</given-names></name><name name-style="western"><surname>Diaz-Uriarte</surname><given-names>R</given-names></name><name name-style="western"><surname>Dopazo</surname><given-names>J</given-names></name></person-group>
					<year>2004</year>
					<article-title>FatiGO: A web tool for finding significant associations of gene
						ontology terms with groups of genes.</article-title>
					<source>Bioinformatics</source>
					<volume>20</volume>
					<fpage>578</fpage>
					<lpage>580</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b019"><label>19</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Al-Shahrour</surname><given-names>F</given-names></name><name name-style="western"><surname>Minguez</surname><given-names>P</given-names></name><name name-style="western"><surname>Vaquerizas</surname><given-names>JM</given-names></name><name name-style="western"><surname>Conde</surname><given-names>L</given-names></name><name name-style="western"><surname>Dopazo</surname><given-names>J</given-names></name></person-group>
					<year>2005</year>
					<article-title>BABELOMICS: A suite of web tools for functional annotation and
						analysis of groups of genes in high-throughput experiments.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>33</volume>
					<fpage>W460</fpage>
					<lpage>W464</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b020"><label>20</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Aoki</surname><given-names>H</given-names></name><name name-style="western"><surname>Motohashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>N</given-names></name><name name-style="western"><surname>Yamazaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamane</surname><given-names>T</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Cooperative and indispensable roles of endothelin 3 and KIT
						signalings in melanocyte development.</article-title>
					<source>Dev Dyn</source>
					<volume>233</volume>
					<fpage>407</fpage>
					<lpage>417</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b021"><label>21</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Adato</surname><given-names>A</given-names></name><name name-style="western"><surname>Lefevre</surname><given-names>G</given-names></name><name name-style="western"><surname>Delprat</surname><given-names>B</given-names></name><name name-style="western"><surname>Michel</surname><given-names>V</given-names></name><name name-style="western"><surname>Michalski</surname><given-names>N</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Usherin, the defective protein in Usher syndrome type IIA, is
						likely to be a component of interstereocilia ankle links in the inner ear
						sensory cells.</article-title>
					<source>Hum Mol Genet</source>
					<volume>14</volume>
					<fpage>3921</fpage>
					<lpage>3932</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b022"><label>22</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Bearer</surname><given-names>EL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>AF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>AH</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mark</surname><given-names>HF</given-names></name><etal/></person-group>
					<year>2000</year>
					<article-title>2E4/Kaptin (KPTN)—A candidate gene for the hearing loss
						locus, DFNA4.</article-title>
					<source>Ann Hum Genet</source>
					<volume>64</volume>
					<fpage>189</fpage>
					<lpage>196</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b023"><label>23</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Oakley</surname><given-names>T</given-names></name><name name-style="western"><surname>Mower</surname><given-names>J</given-names></name><name name-style="western"><surname>Shimmin</surname><given-names>LC</given-names></name><name name-style="western"><surname>Yim</surname><given-names>S</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Molecular evolution of bat color vision genes.</article-title>
					<source>Mol Biol Evol</source>
					<volume>21</volume>
					<fpage>295</fpage>
					<lpage>302</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b024"><label>24</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Stolze</surname><given-names>I</given-names></name><name name-style="western"><surname>Berchner-Pfannschmidt</surname><given-names>U</given-names></name><name name-style="western"><surname>Freitag</surname><given-names>P</given-names></name><name name-style="western"><surname>Wotzlaw</surname><given-names>C</given-names></name><name name-style="western"><surname>Rossler</surname><given-names>J</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Hypoxia-inducible erythropoietin gene expression in human
						neuroblastoma cells.</article-title>
					<source>Blood</source>
					<volume>100</volume>
					<fpage>2623</fpage>
					<lpage>2628</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b025"><label>25</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Onochie</surname><given-names>CI</given-names></name><name name-style="western"><surname>Korngut</surname><given-names>LM</given-names></name><name name-style="western"><surname>Vanhorne</surname><given-names>JB</given-names></name><name name-style="western"><surname>Myers</surname><given-names>SM</given-names></name><name name-style="western"><surname>Michaud</surname><given-names>D</given-names></name><etal/></person-group>
					<year>2000</year>
					<article-title>Characterisation of the human GFRalpha-3 locus and investigation
						of the gene in Hirschsprung disease.</article-title>
					<source>J Med Genet</source>
					<volume>37</volume>
					<fpage>674</fpage>
					<lpage>679</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b026"><label>26</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Wrabetz</surname><given-names>L</given-names></name><name name-style="western"><surname>Feltri</surname><given-names>ML</given-names></name></person-group>
					<year>2001</year>
					<article-title>Do Schwann cells stop, DR(o)P2, and roll?</article-title>
					<source>Neuron</source>
					<volume>30</volume>
					<fpage>642</fpage>
					<lpage>644</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b027"><label>27</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ernst</surname><given-names>C</given-names></name><name name-style="western"><surname>Christie</surname><given-names>BR</given-names></name></person-group>
					<year>2005</year>
					<article-title>The putative neural stem cell marker, nestin, is expressed in
						heterogeneous cell types in the adult rat neocortex.</article-title>
					<source>Neuroscience</source>
					<volume>138</volume>
					<fpage>183</fpage>
					<lpage>188</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b028"><label>28</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kabashima</surname><given-names>K</given-names></name><name name-style="western"><surname>Sakata</surname><given-names>D</given-names></name><name name-style="western"><surname>Nagamachi</surname><given-names>M</given-names></name><name name-style="western"><surname>Miyachi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Inaba</surname><given-names>K</given-names></name><etal/></person-group>
					<year>2003</year>
					<article-title>Prostaglandin E2-EP4 signaling initiates skin immune responses by
						promoting migration and maturation of Langerhans cells.</article-title>
					<source>Nat Med</source>
					<volume>9</volume>
					<fpage>744</fpage>
					<lpage>749</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b029"><label>29</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Del Corno</surname><given-names>M</given-names></name><name name-style="western"><surname>Gauzzi</surname><given-names>MC</given-names></name><name name-style="western"><surname>Penna</surname><given-names>G</given-names></name><name name-style="western"><surname>Belardelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Adorini</surname><given-names>L</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Human immunodeficiency virus type 1 gp120 and other activation
						stimuli are highly effective in triggering alpha interferon and CC chemokine
						production in circulating plasmacytoid but not myeloid dendritic cells.</article-title>
					<source>J Virol</source>
					<volume>79</volume>
					<fpage>12597</fpage>
					<lpage>12601</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b030"><label>30</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ritter</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>MY</given-names></name><name name-style="western"><surname>Grimm</surname><given-names>CF</given-names></name><name name-style="western"><surname>Weth</surname><given-names>R</given-names></name><name name-style="western"><surname>Mohr</surname><given-names>L</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Immunoregulation of dendritic and T cells by alpha-fetoprotein in
						patients with hepatocellular carcinoma.</article-title>
					<source>J Hepatol</source>
					<volume>41</volume>
					<fpage>999</fpage>
					<lpage>1007</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b031"><label>31</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Sargent</surname><given-names>IL</given-names></name></person-group>
					<year>2005</year>
					<article-title>Does “soluble” HLA-G really exist? Another
						twist to the tale.</article-title>
					<source>Mol Hum Reprod</source>
					<volume>11</volume>
					<fpage>695</fpage>
					<lpage>698</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b032"><label>32</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Dard</surname><given-names>P</given-names></name><name name-style="western"><surname>Lefranc</surname><given-names>MP</given-names></name><name name-style="western"><surname>Osipova</surname><given-names>L</given-names></name><name name-style="western"><surname>Sanchez-Mazas</surname><given-names>A</given-names></name></person-group>
					<year>2001</year>
					<article-title>DNA sequence variability of IGHG3 alleles associated to the main
						G3m haplotypes in human populations.</article-title>
					<source>Eur J Hum Genet</source>
					<volume>9</volume>
					<fpage>765</fpage>
					<lpage>772</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b033"><label>33</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Naruse</surname><given-names>TK</given-names></name><name name-style="western"><surname>Kawata</surname><given-names>H</given-names></name><name name-style="western"><surname>Inoko</surname><given-names>H</given-names></name><name name-style="western"><surname>Isshiki</surname><given-names>G</given-names></name><name name-style="western"><surname>Yamano</surname><given-names>K</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>The HLA-DOB gene displays limited polymorphism with only one
						amino acid substitution.</article-title>
					<source>Tissue Antigens</source>
					<volume>59</volume>
					<fpage>512</fpage>
					<lpage>519</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b034"><label>34</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Karkkainen</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Haiko</surname><given-names>P</given-names></name><name name-style="western"><surname>Sainio</surname><given-names>K</given-names></name><name name-style="western"><surname>Partanen</surname><given-names>J</given-names></name><name name-style="western"><surname>Taipale</surname><given-names>J</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Vascular endothelial growth factor C is required for sprouting of
						the first lymphatic vessels from embryonic veins.</article-title>
					<source>Nat Immunol</source>
					<volume>5</volume>
					<fpage>74</fpage>
					<lpage>80</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b035"><label>35</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Moroy</surname><given-names>T</given-names></name><name name-style="western"><surname>Geisen</surname><given-names>C</given-names></name></person-group>
					<year>2004</year>
					<article-title>Cyclin E.</article-title>
					<source>Int J Biochem Cell Biol</source>
					<volume>36</volume>
					<fpage>1424</fpage>
					<lpage>1439</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b036"><label>36</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Pedrini</surname><given-names>E</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>A</given-names></name><name name-style="western"><surname>Valente</surname><given-names>EM</given-names></name><name name-style="western"><surname>Maini</surname><given-names>V</given-names></name><name name-style="western"><surname>Capponcelli</surname><given-names>S</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Novel EXT1 and EXT2 mutations identified by DHPLC in Italian
						patients with multiple osteochondromas.</article-title>
					<source>Hum Mutat</source>
					<volume>26</volume>
					<fpage>280</fpage>
				</element-citation></ref><ref id="pcbi-0020038-b037"><label>37</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Nagata</surname><given-names>K</given-names></name><name name-style="western"><surname>Asano</surname><given-names>T</given-names></name><name name-style="western"><surname>Nozawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Inagaki</surname><given-names>M</given-names></name></person-group>
					<year>2004</year>
					<article-title>Biochemical and cell biological analyses of a mammalian septin
						complex, Sept7/9b/11.</article-title>
					<source>J Biol Chem</source>
					<volume>279</volume>
					<fpage>55895</fpage>
					<lpage>55904</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b038"><label>38</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>CY</given-names></name><name name-style="western"><surname>Kong</surname><given-names>AN</given-names></name></person-group>
					<year>2005</year>
					<article-title>Induction of phase I, II, and III drug metabolism/transport by
						xenobiotics.</article-title>
					<source>Arch Pharm Res</source>
					<volume>28</volume>
					<fpage>249</fpage>
					<lpage>268</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b039"><label>39</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ciaccio</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Jaiswal</surname><given-names>AK</given-names></name><name name-style="western"><surname>Tew</surname><given-names>KD</given-names></name></person-group>
					<year>1994</year>
					<article-title>Regulation of human dihydrodiol dehydrogenase by Michael acceptor
						xenobiotics.</article-title>
					<source>J Biol Chem</source>
					<volume>269</volume>
					<fpage>15558</fpage>
					<lpage>15562</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b040"><label>40</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Van der Bliek</surname><given-names>AM</given-names></name><name name-style="western"><surname>Baas</surname><given-names>F</given-names></name><name name-style="western"><surname>Ten Houte de Lange</surname><given-names>T</given-names></name><name name-style="western"><surname>Kooiman</surname><given-names>PM</given-names></name><name name-style="western"><surname>Van der Velde-Koerts</surname><given-names>T</given-names></name><etal/></person-group>
					<year>1987</year>
					<article-title>The human mdr3 gene encodes a novel P-glycoprotein homologue and
						gives rise to alternatively spliced mRNAs in liver.</article-title>
					<source>EMBO J</source>
					<volume>6</volume>
					<fpage>3325</fpage>
					<lpage>3331</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b041"><label>41</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Perez</surname><given-names>C</given-names></name><name name-style="western"><surname>Auriol</surname><given-names>J</given-names></name><name name-style="western"><surname>Gerst</surname><given-names>C</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>BA</given-names></name><name name-style="western"><surname>Egly</surname><given-names>JM</given-names></name></person-group>
					<year>1999</year>
					<article-title>Genomic organization and promoter characterization of two human
						UHS keratin genes.</article-title>
					<source>Gene</source>
					<volume>227</volume>
					<fpage>137</fpage>
					<lpage>148</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b042"><label>42</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Zimek</surname><given-names>A</given-names></name><name name-style="western"><surname>Weber</surname><given-names>K</given-names></name></person-group>
					<year>2005</year>
					<article-title>Terrestrial vertebrates have two keratin gene clusters; striking
						differences in teleost fish.</article-title>
					<source>Eur J Cell Biol</source>
					<volume>84</volume>
					<fpage>623</fpage>
					<lpage>635</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b043"><label>43</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>M</given-names></name><name name-style="western"><surname>Kasahara</surname><given-names>N</given-names></name><name name-style="western"><surname>Keene</surname><given-names>DR</given-names></name><name name-style="western"><surname>Chan</surname><given-names>L</given-names></name><name name-style="western"><surname>Hoeffler</surname><given-names>WK</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Restoration of type VII collagen expression and function in
						dystrophic epidermolysis bullosa.</article-title>
					<source>Nat Genet</source>
					<volume>32</volume>
					<fpage>670</fpage>
					<lpage>675</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b044"><label>44</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Cassidy</surname><given-names>AJ</given-names></name><name name-style="western"><surname>van Steensel</surname><given-names>MA</given-names></name><name name-style="western"><surname>Steijlen</surname><given-names>PM</given-names></name><name name-style="western"><surname>van Geel</surname><given-names>M</given-names></name><name name-style="western"><surname>Velden</surname><given-names>J</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>A homozygous missense mutation in TGM5 abolishes epidermal
						transglutaminase 5 activity and causes acral peeling skin syndrome.</article-title>
					<source>Am J Hum Genet</source>
					<volume>77</volume>
					<fpage>909</fpage>
					<lpage>917</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b045"><label>45</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Mahler</surname><given-names>B</given-names></name><name name-style="western"><surname>Gocken</surname><given-names>T</given-names></name><name name-style="western"><surname>Brojan</surname><given-names>M</given-names></name><name name-style="western"><surname>Childress</surname><given-names>S</given-names></name><name name-style="western"><surname>Spandau</surname><given-names>DF</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Keratin 2e: A marker for murine nipple epidermis.</article-title>
					<source>Cells Tissues Organs</source>
					<volume>176</volume>
					<fpage>169</fpage>
					<lpage>177</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b046"><label>46</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Kaplan</surname><given-names>M</given-names></name><name name-style="western"><surname>Ray</surname><given-names>D</given-names></name><name name-style="western"><surname>Ray</surname><given-names>D</given-names></name><name name-style="western"><surname>Zacharek</surname><given-names>S</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>Demethylation of ITGAL (CD11a) regulatory sequences in systemic
						lupus erythematosus.</article-title>
					<source>Arthritis Rheum</source>
					<volume>46</volume>
					<fpage>1282</fpage>
					<lpage>1291</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b047"><label>47</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Nicklin</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Barton</surname><given-names>JL</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M</given-names></name><name name-style="western"><surname>FitzGerald</surname><given-names>MG</given-names></name><name name-style="western"><surname>Duff</surname><given-names>GW</given-names></name><etal/></person-group>
					<year>2002</year>
					<article-title>A sequence-based map of the nine genes of the human interleukin-1
						cluster.</article-title>
					<source>Genomics</source>
					<volume>79</volume>
					<fpage>718</fpage>
					<lpage>725</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b048"><label>48</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>J</given-names></name><name name-style="western"><surname>Do</surname><given-names>J</given-names></name><name name-style="western"><surname>Widdicombe</surname><given-names>JH</given-names></name><name name-style="western"><surname>Machen</surname><given-names>TE</given-names></name></person-group>
					<year>2005</year>
					<article-title>Innate Immune Responses of Human Tracheal Epithelium to P.
						aeruginosa flagellin, TNF-α and IL1-β.</article-title>
					<source>Am J Physiol Cell Physiol</source>
					<volume>290</volume>
					<fpage>C678</fpage>
					<lpage>C690</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b049"><label>49</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Sebastiani</surname><given-names>S</given-names></name><name name-style="western"><surname>Allavena</surname><given-names>P</given-names></name><name name-style="western"><surname>Albanesi</surname><given-names>C</given-names></name><name name-style="western"><surname>Nasorri</surname><given-names>F</given-names></name><name name-style="western"><surname>Bianchi</surname><given-names>G</given-names></name><etal/></person-group>
					<year>2001</year>
					<article-title>Chemokine receptor expression and function in CD4+ T
						lymphocytes with regulatory activity.</article-title>
					<source>J Immunol</source>
					<volume>166</volume>
					<fpage>996</fpage>
					<lpage>1002</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b050"><label>50</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Kearns</surname><given-names>AE</given-names></name><name name-style="western"><surname>Donohue</surname><given-names>MM</given-names></name><name name-style="western"><surname>Sanyal</surname><given-names>B</given-names></name><name name-style="western"><surname>Demay</surname><given-names>MB</given-names></name></person-group>
					<year>2001</year>
					<article-title>Cloning and characterization of a novel protein kinase that
						impairs osteoblast differentiation in vitro.</article-title>
					<source>J Biol Chem</source>
					<volume>276</volume>
					<fpage>42213</fpage>
					<lpage>42218</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b051"><label>51</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Pochampally</surname><given-names>RR</given-names></name><name name-style="western"><surname>Horwitz</surname><given-names>EM</given-names></name><name name-style="western"><surname>DiGirolamo</surname><given-names>CM</given-names></name><name name-style="western"><surname>Stokes</surname><given-names>DS</given-names></name><name name-style="western"><surname>Prockop</surname><given-names>DJ</given-names></name></person-group>
					<year>2005</year>
					<article-title>Correction of a mineralization defect by overexpression of a
						wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with
						osteogenesis imperfecta: A strategy for rescuing mutations that produce
						dominant-negative protein defects.</article-title>
					<source>Gene Ther</source>
					<volume>12</volume>
					<fpage>1119</fpage>
					<lpage>1125</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b052"><label>52</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>M</given-names></name><name name-style="western"><surname>Septier</surname><given-names>D</given-names></name><name name-style="western"><surname>Rapoport</surname><given-names>O</given-names></name><name name-style="western"><surname>Iozzo</surname><given-names>RV</given-names></name><name name-style="western"><surname>Young</surname><given-names>MF</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Targeted disruption of two small leucine-rich proteoglycans,
						biglycan and decorin, excerpts divergent effects on enamel and dentin
						formation.</article-title>
					<source>Calcified Tissue Int</source>
					<volume>77</volume>
					<fpage>297</fpage>
					<lpage>310</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b053"><label>53</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Raymond</surname><given-names>MH</given-names></name><name name-style="western"><surname>Schutte</surname><given-names>BC</given-names></name><name name-style="western"><surname>Torner</surname><given-names>JC</given-names></name><name name-style="western"><surname>Burns</surname><given-names>TL</given-names></name><name name-style="western"><surname>Willing</surname><given-names>MC</given-names></name></person-group>
					<year>1999</year>
					<article-title>Osteocalcin: Genetic and physical mapping of the human gene BGLAP
						and its potential role in postmenopausal osteoporosis.</article-title>
					<source>Genomics</source>
					<volume>60</volume>
					<fpage>210</fpage>
					<lpage>217</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b054"><label>54</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Rittenberg</surname><given-names>B</given-names></name><name name-style="western"><surname>Partridge</surname><given-names>E</given-names></name><name name-style="western"><surname>Baker</surname><given-names>G</given-names></name><name name-style="western"><surname>Clokie</surname><given-names>C</given-names></name><name name-style="western"><surname>Zohar</surname><given-names>R</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Regulation of BMP-induced ectopic bone formation by Ahsg.</article-title>
					<source>J Orthop Res</source>
					<volume>23</volume>
					<fpage>653</fpage>
					<lpage>662</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b055"><label>55</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>K</given-names></name><name name-style="western"><surname>Nabeshima</surname><given-names>T</given-names></name></person-group>
					<year>2004</year>
					<article-title>Interaction of BDNF/TrkB signaling with NMDA receptor in learning
						and memory.</article-title>
					<source>Drug News Perspect</source>
					<volume>17</volume>
					<fpage>435</fpage>
					<lpage>438</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b056"><label>56</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>J</given-names></name><name name-style="western"><surname>Crosbie</surname><given-names>J</given-names></name><name name-style="western"><surname>Wigg</surname><given-names>K</given-names></name><name name-style="western"><surname>Ickowicz</surname><given-names>A</given-names></name><name name-style="western"><surname>Pathare</surname><given-names>T</given-names></name><etal/></person-group>
					<year>2004</year>
					<article-title>Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A)
						gene as a positional candidate for attention-deficit/hyperactivity disorder
						in the 16p13 region.</article-title>
					<source>Mol Psychiatry</source>
					<volume>9</volume>
					<fpage>494</fpage>
					<lpage>499</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b057"><label>57</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Pfankuch</surname><given-names>T</given-names></name><name name-style="western"><surname>Rizk</surname><given-names>A</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>R</given-names></name><name name-style="western"><surname>Poage</surname><given-names>C</given-names></name><name name-style="western"><surname>Raber</surname><given-names>J</given-names></name></person-group>
					<year>2005</year>
					<article-title>Role of circulating androgen levels in effects of apoE4 on
						cognitive function.</article-title>
					<source>Brain Res</source>
					<volume>1053</volume>
					<fpage>88</fpage>
					<lpage>96</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b058"><label>58</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Smanik</surname><given-names>PA</given-names></name><name name-style="western"><surname>Ryu</surname><given-names>KY</given-names></name><name name-style="western"><surname>Theil</surname><given-names>KS</given-names></name><name name-style="western"><surname>Mazzaferri</surname><given-names>EL</given-names></name><name name-style="western"><surname>Jhiang</surname><given-names>SM</given-names></name></person-group>
					<year>1997</year>
					<article-title>Expression, exon–intron organization, and chromosome
						mapping of the human sodium iodide symporter.</article-title>
					<source>Endocrinology</source>
					<volume>138</volume>
					<fpage>3555</fpage>
					<lpage>3558</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b059"><label>59</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JW</given-names></name><name name-style="western"><surname>Choi</surname><given-names>HS</given-names></name><name name-style="western"><surname>Gyuris</surname><given-names>J</given-names></name><name name-style="western"><surname>Brent</surname><given-names>R</given-names></name><name name-style="western"><surname>Moore</surname><given-names>DD</given-names></name></person-group>
					<year>1995</year>
					<article-title>Two classes of proteins dependent on either the presence or
						absence of thyroid hormone for interaction with the thyroid hormone
						receptor.</article-title>
					<source>Mol Endocrinol</source>
					<volume>9</volume>
					<fpage>243</fpage>
					<lpage>254</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b060"><label>60</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Vamvakopoulos</surname><given-names>NC</given-names></name><name name-style="western"><surname>Monahan</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Kourides</surname><given-names>IA</given-names></name></person-group>
					<year>1980</year>
					<article-title>Synthesis, cloning, and identification of DNA sequences
						complementary to mRNAs for alpha and beta subunits of thyrotropin.</article-title>
					<source>Proc Natl Acad Sci U S A</source>
					<volume>77</volume>
					<fpage>3149</fpage>
					<lpage>3153</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b061"><label>61</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Schipani</surname><given-names>E</given-names></name><name name-style="western"><surname>Karga</surname><given-names>H</given-names></name><name name-style="western"><surname>Karaplis</surname><given-names>AC</given-names></name><name name-style="western"><surname>Potts</surname><given-names>JT</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Kronenberg</surname><given-names>HM</given-names></name><etal/></person-group>
					<year>1993</year>
					<article-title>Identical complementary deoxyribonucleic acids encode a human
						renal and bone parathyroid hormone (PTH)/PTH–related peptide
						receptor.</article-title>
					<source>Endocrinology</source>
					<volume>132</volume>
					<fpage>2157</fpage>
					<lpage>2165</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b062"><label>62</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Amato</surname><given-names>F</given-names></name><name name-style="western"><surname>Warnes</surname><given-names>GM</given-names></name><name name-style="western"><surname>Kirby</surname><given-names>CA</given-names></name><name name-style="western"><surname>Norman</surname><given-names>RJ</given-names></name></person-group>
					<year>2002</year>
					<article-title>Infertility caused by HCG autoantibody.</article-title>
					<source>J Clin Endocrinol Metab</source>
					<volume>87</volume>
					<fpage>993</fpage>
					<lpage>997</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b063"><label>63</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>FC</given-names></name><name name-style="western"><surname>Li</surname><given-names>WH</given-names></name></person-group>
					<year>2001</year>
					<article-title>Genomic divergences between humans and other hominoids and the
						effective population size of the common ancestor of humans and chimpanzees.</article-title>
					<source>Am J Hum Genet</source>
					<volume>68</volume>
					<fpage>444</fpage>
					<lpage>456</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b064"><label>64</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ge</surname><given-names>H</given-names></name><name name-style="western"><surname>Walhout</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Vidal</surname><given-names>M</given-names></name></person-group>
					<year>2003</year>
					<article-title>Integrating “omic” information: A bridge
						between genomics and systems biology.</article-title>
					<source>Trends Genet</source>
					<volume>19</volume>
					<fpage>551</fpage>
					<lpage>560</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b065"><label>65</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Lander</surname><given-names>ES</given-names></name><name name-style="western"><surname>Linton</surname><given-names>LM</given-names></name><name name-style="western"><surname>Birren</surname><given-names>B</given-names></name><name name-style="western"><surname>Nusbaum</surname><given-names>C</given-names></name><name name-style="western"><surname>Zody</surname><given-names>MC</given-names></name><etal/></person-group>
					<year>2001</year>
					<article-title>Initial sequencing and analysis of the human genome.</article-title>
					<source>Nature</source>
					<volume>409</volume>
					<fpage>860</fpage>
					<lpage>921</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b066"><label>66</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Hubbard</surname><given-names>T</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>D</given-names></name><name name-style="western"><surname>Caccamo</surname><given-names>M</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>Ensembl 2005.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>33</volume>
					<fpage>D447</fpage>
					<lpage>D453</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b067"><label>67</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Thompson</surname><given-names>JD</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>DG</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>TJ</given-names></name></person-group>
					<year>1994</year>
					<article-title>CLUSTAL W: Improving the sensitivity of progressive multiple
						sequence alignment through sequence weighting, position-specific gap
						penalties and weight matrix choice.</article-title>
					<source>Nucleic Acids Res</source>
					<volume>22</volume>
					<fpage>4673</fpage>
					<lpage>4680</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b068"><label>68</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Blair Hedges</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group>
					<year>2003</year>
					<article-title>Genomic clocks and evolutionary timescales.</article-title>
					<source>Trends Genet</source>
					<volume>19</volume>
					<fpage>200</fpage>
					<lpage>206</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b069"><label>69</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WH</given-names></name></person-group>
					<year>1993</year>
					<article-title>Unbiased estimation of the rates of synonymous and nonsynonymous
						substitution.</article-title>
					<source>J Mol Evol</source>
					<volume>36</volume>
					<fpage>96</fpage>
					<lpage>99</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b070"><label>70</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Robinson-Rechavi</surname><given-names>M</given-names></name><name name-style="western"><surname>Huchon</surname><given-names>D</given-names></name></person-group>
					<year>2000</year>
					<article-title>RRTree: Relative-rate tests between groups of sequences on a
						phylogenetic tree.</article-title>
					<source>Bioinformatics</source>
					<volume>16</volume>
					<fpage>296</fpage>
					<lpage>297</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b071"><label>71</label><element-citation publication-type="other" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Sokal</surname><given-names>R</given-names></name></person-group>
					<year>1981</year>
					<source>Biometry. The principles and practice of statistics in biological
						research</source>
					<publisher-loc>New York</publisher-loc>
					<publisher-name>W. H. Freeman and Company</publisher-name>
					<fpage>859</fpage>
					<comment>p.</comment>
				</element-citation></ref><ref id="pcbi-0020038-b072"><label>72</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Ihaka</surname><given-names>R</given-names></name><name name-style="western"><surname>Gentleman</surname><given-names>R</given-names></name></person-group>
					<year>1996</year>
					<article-title>R: A Language for Data Analysis and Graphics.</article-title>
					<source>J Comput Graph Stat</source>
					<volume>5</volume>
					<fpage>299</fpage>
					<lpage>314</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b073"><label>73</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Benjamini</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hochberg</surname><given-names>Y</given-names></name></person-group>
					<year>1995</year>
					<article-title>Controlling the false discovery rate: A practical and powerful
						approach to multiple testing.</article-title>
					<source>J Roy Stat Soc B</source>
					<volume>57</volume>
					<fpage>289</fpage>
					<lpage>300</lpage>
				</element-citation></ref><ref id="pcbi-0020038-b074"><label>74</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Eilbeck</surname><given-names>K</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>SE</given-names></name><name name-style="western"><surname>Mungall</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yandell</surname><given-names>M</given-names></name><name name-style="western"><surname>Stein</surname><given-names>L</given-names></name><etal/></person-group>
					<year>2005</year>
					<article-title>The Sequence Ontology: A tool for the unification of genome
						annotations.</article-title>
					<source>Genome Biol</source>
					<volume>6</volume>
					<fpage>R44</fpage>
				</element-citation></ref><ref id="pcbi-0020038-b075"><label>75</label><element-citation publication-type="journal" xlink:type="simple">
					<person-group person-group-type="author"><name name-style="western"><surname>Benjamini</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yekutieli</surname><given-names>D</given-names></name></person-group>
					<year>2001</year>
					<article-title>The control of the false discovery rate in multiple testing under
						dependency.</article-title>
					<source>Ann Stat</source>
					<volume>29</volume>
					<fpage>1165</fpage>
					<lpage>1188</lpage>
				</element-citation></ref></ref-list></back></article>